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INTERACTION BETWEEN THE METABOLISM OF KETONE BODIES IN BRAIN

TISSUE AND NEUROLOGICAL DISORDERS
CHAN-CHIH HSIAO
ABSTRACT
Regulation of brain metabolism and cerebral blood flow involves complex control

systems with several interacting variables at both cellular and organ levels. Quantitative
understanding of the spatially and temporally heterogeneous brain control mechanisms
during internal and external stimuli requires the development and validation of a

computational (mathematical) model of metabolic processes in brain tissue. A
computational model of the biochemical pathways in brain is presented in this paper. The
model structure consists of neurons, astrocytes, and a surrounding capillary network.

Glucose is the major oxidative energy substrate in the brain. However, under

hypoglycemic conditions such as during diet or fasting or other conditions induced by
pathology, alternate energy substrates such as ketone bodies supplement glucose

metabolism. In this study, the increased activity of the glutamate-glutamine shuttle is
studied in conjunction with the observation that ketosis results in lower lactate levels in

brain. A model of ketosis in brain is used to examine the partitioning of carbon units

entering the tricarboxylic acid cycle at the level of acetyl-CoA. Using Flux Balance
Analysis, we hypothesized that the carbon fluxes would shift towards an increase in flux
rates stemming from the metabolism of ketone bodies with a proportional decrease in the

flux of lactate derived from the astrocyte-neuron lactate shuttle. It was found that the
model could predict an estimation of compartmentalized flux-balances (mitochondrial
cytosolic) in standard and ketogenic diet conditions. Ketone body metabolism was found

iii

to be loosely coupled with glucose metabolism (astrocyte-neuron) suggesting important

therapeutic implications.
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CHAPTER I

INTRODUCTION

A normal daily life diet consists of three main types of nutrients: carbohydrates

(60%), lipids (20%), and proteins (20%). The process of digestion transforms
carbohydrates into glucose (Kemppainen et al., 2005). Our brain consumes around 25% of

whole body’s glucose at rest, and 14% during exercise. This change occurs because a
certain amount of glucose is needed to provide energy for the muscles. Neurons use not
only glucose, but also lactate as a fuel. Astrocytes produce lactate from pyruvate and export

it to neurons by means of the astrocyte-neuron lactate shuttle (ANLS).
In neurons, about 10% of pyruvate is derived from glycolysis and 90% from the

lactate shuttle. Lipids are digested into fatty acids in the small intestine and then transported

to the liver. The fatty acids can be converted into ketone bodies, including acetone,
acetoacetate, and BHB (P-hydroxybutyrate). Acetone and acetoacetate are then

metabolized into BHB, and BHB is delivered to the neurons and transformed into acetyl
Co-A. 65% of acetyl Co-A is derived from pyruvate and 35% from BHB under normal diet.

Acetyl Co-A, that is produced by metabolizing glucose, lactate, or ketones is then
incorporated into tricarboxylic acid (TCA) cycle. Brain tissue main metabolic pathways
are as shown schematically in Figure I.1 below.

1

Figure I.1. Brain tissue main metabolic pathways. (Russell et al., 2002)
Glucose and brain tissue

Brain consists mostly of neurons and astrocytes. The function of neurons is sensing,
while astrocytes are supporting cells that provide nutrients to neurons. Glucose enters the

cells through glucose transporters, or GLUTs. While each individual astrocyte has the same
glucose transporting rate than those of neurons, the number of astrocytes in the brain is ten

times that of neurons. Therefore, the total astrocytic glucose intake is approximately ten
times that of neurons. When glucose enters cells, it is metabolized through glycolysis and
the TCA cycle, which generates NADH (reduced form of nicotinamide adenine
dinucleotide), ATP (adenosine tri-phosphate), carbon dioxide, and water.

The glycolysis and TCA cycle (cf. Figure I.2) are metabolic pathways, which

consist of more than twenty steps. In the process of glycolysis, free radicals, the molecules
that contain an unpaired electron, are produced in the conversion of glyceraldehyde 3-

phosphate (GADP) to 1,3-bisphosphoglyceric acid (1, 3 BPG). In the process of TCA cycle,
the steps which produce NADH will generate free radicals when NADH metabolize to ATP.

2

A

B

Figure I.2. (A) Glycolysis and (B) TCA cycle (Salim, 2017).

3

Statement of the Problem

The degeneration or loss of functionality of different parts of the brain is one of
the reasons typically associated with a variety of neurological disorders, such as
Parkinson’s Disease (PD) and Alzheimer’s disease. For instance, a widely accepted cause

of PD is the degeneration of the substantia nigra, which secretes dopamine. However, the
detailed mechanisms underlying cell death in the substantia nigra have not yet been
elucidated (Chen et al., 2007). One possible mechanism that has been highlighted as a
potential cause for the loss of functionality of neurons is the metabolism of glucose in

these cells (or glycolysis) (Salim, 2017). Glycolysis typically produces significant levels

of reactive oxygen species (ROS); which could lead to mitochondrial dysfunction in
neurons (Salim, 2017). In order to find the interrelationship of free radicals and neuron
dysfunction, it is need to find the free radicals dynamic and steady state level. One

possible method would be to measure, directly or indirectly, the dynamic and steady state

concentrations levels of GADP and 1, 3 BPG. It needs evaluate the dynamic and steady
state concentrations in neuron. However, due to neurons are separated each other and

surrounded by astrocytes, in vivo evaluation of neuronal glycolysis and TCA cycle is
difficult (Kemppainen, 2005).

A valuable complement to experiments is the availability of predictive tools that

connect levels of metabolites or specific fluxes whose values can be determined by
already have well-established experimental techniques, with fluxes and dynamics of
pathways that can potentially explain these losses in functionality. Modeling of brain

tissue has been widely addressed in the literature (Aubert et al., 2005; Perrillat-Mercerot

et al., 2019). These efforts, however, have focused on specific pathways or substrate
4

dynamics. Mulukutla (Mulukutla et al., 2015), for example, completed detailed models of
the glycolysis and TCA cycle in rats ovary cells, but did not attempt to build

communication pathways between neurons and astrocytes, nor they accounted for

different dynamics in each cell. Patel and coworkers (Patel et al., 2004) concentrated their
attention on some of the inter-compartment (cells) pathways, particularly the glutamate
glutamine cycle and GABA shunt, but simplified the basic intra-compartment pathways.

These groups studied tissue metabolic dynamics for glucose as the main energy substrate,
they did not consider the metabolic effect of ketone bodies (KB) in their models. Aubert

and coworkers (Aubert & Costalat, 2005) developed a simplified model focusing on the
lactate shuttle and transporters (GLUT and MCT); these authors, however, did not

consider the potential of effect of lactate fluxes and levels on the transporters affinity, nor
they accounted for different isoforms of these transporters (GLUT1-4 and MCT1-4).
More recently, Heiske (Heiske et al., 2014) provided complex I modeling equations, but

did not connect the model to the onset or progression of neurological disorders.

This study will combine different aspects of brain metabolism models, like those

referred above, into an integrated model by adding the missing connections and
interrelations. Since the most important aim of this study is to formulate and validate a
metabolic model, which can replicate and shed light on experimental observations and

phenomena; we envision a model with significantly increased complexity. Particular
attention will be paid to the pathways that can explain the differences and limitations
when ketone bodies are considered as a substitute or complementary substrate to sustain

brain metabolism.
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This model will enable in silico experiments, which will be validated by in vivo

and in vitro results. There have been several Parkinson’s disease-related studies, such as
those examining mass flux transport between brain cells, as well as studies on membrane
proteins. However, the results from all these studies have not yet been integrated in a

mathematical model of brain metabolism.

A computer model can be formulated to integrate the major inter and intra-cellular
pathways, it can be developed aimed to include all species, reactions, transporters, fluxes,

and parameters of glycolysis and TCA cycle of neurons and astrocytes. Such a model will

consist of more than 60 species, more than 100 fluxes, with more than 200 parameters. A
model with such a high complexity may not be realizable or not robust due to the intricate

interrelation between fluxes and parameter values that can affect the prediction of the
dynamics for the concentrations and fluxes of the different model metabolites. Therefore,

a balance between complexity and robustness is necessary. If the number of species,
reactions, fluxes, and parameters could be reduced, without significantly affecting the
model predictive ability, a more robust model will result.

Once a computer model is validated, this model will prove to be an efficient tool
to study potential causes, which can accelerate or slow down brain deterioration
phenomena associated to the onset and progression of neurological disorder. Moreover,

the model can identify fluxes and species, either dynamic and steady state levels, that

could be used to formulate or validate therapies to control the deterioration of areas of
interest in brain tissue. For example, the model can be used to examine the link of

Complex I denaturation and brain tissue deterioration rates, with ratios of glucose to KB

in the diet. Similarly, and model can examine the inter-relation of tissue deterioration
6

rates with the activity of transport protein which control the flux of glucose and ketone

bodies into the brain cells.

Materials and Methods
This research will formulate a lumped-parameter in silico model to describe the

dynamics of concentrations and mass transport fluxes under isothermal conditions in
brain tissue. The model aims to predict fluxes and concentration levels for all the

reactions (cf. Figure I.2) in the glycolysis and tri-carboxylic acid cycle, along the most
significant pathways (cf. Figure I.1 ) accounting for inter-cellular transport in brain
metabolism.

This model will be validated using literature data for selected concentration and
fluxes levels collected during stimulated (dynamic) brain metabolism experiments as well
as at steady-state. We will demonstrate how the model can be simplified, and highlight

how models with different levels of complexity can be used to run in-silico experiments.
These studies are anticipated to predict critical metabolic phenomena, formulate
conditions for in-vivo experiments, and identify measurements required to elucidate the

interrelation between metabolic pathways and cell functionality.
Initially,

an in silico model including all species, fluxes, metabolisms, and

transporters, for the glycolysis and TCA cycle, both in astrocytes and neurons, will be
formulated.
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This model will be completed by assistive metabolic pathways, such as the GABA

shunt, the glutamate-glutamine cycle, and the astrocyte-neuron lactate shuttle. The
resulting model is very high in complexity.

An essential goal in the formulation and development of in-silico models is their

reliability and robustness as predictive tools. Cognizant that the reliability of these models

is directly related to the number of adjustable parameters, the complexity of the model and

uncertainty of its parameters will be examined sequentially as follows.
The first step is to the significance of each metabolic reaction under the light of its

thermodynamic feasibility. Some reactions which have small reaction Gibb’s free energy

(AG) will be neglected. Because small AG reaction implies that it is a fast equilibrium
reactions, and is not a rate determined step. The reaction AG is the difference of species

formation AG. We find the standard formation from reference. Then we consider the

enthalpy, change number of species, total number of hydrogen atoms in the species to
calculate transformed A G. Due to ATP and NADH will involve in some reactions of

glycolysis and TCA cycle, we will consider pH, ATP/ADP, NADH/NAD levels and
calculate further transformed formation Gibbs energy in neuron and astrocyte. Here, we

have the species formation AG, and we can calculate reaction AG by the difference of

species formation AG. However, our system is in steady state and is not in equilibrium,

we need consider the species steady state concentration to calibrate reaction AG. After
these steps, the outputs are steady state reaction AG of every step of glycolysis and TCA

cycle. Then next step is neglecting the reactions whose AG are close to zero. Because the

reactions with small AG implies they are fast arriving equilibrium reactions. However, the
8

steps which produce NADH will not be neglected, because free radicals will be produced
when NADH metabolizing to ATP. The free radicals producing steps are what we

concerned, because free radicals might affect dysfunction of brain tissues.
Using Constrained Optimization to examine Enzymatic Activity.

In every steps of glycolysis, we know metabolic and transporter flux balance

equation of Haldane relationship. This relationship includes rate constant of reaction and

transportation, affinity of enzyme and transporter, species concentration, and reaction flux
rate.

Next, using enzyme activity and minimum non-linear constrained optimization to

determine thermodynamic driving force (AG) and concentrations. The steps of constrained
optimization is based on Beard and Qian’s research(Beard & Qian, 2005). In their research,
we know the standard reaction A G, which is not calibrate by the steady state concentration,
and we know all fluxes of all reactions under different modes, species partition coefficients,

stoichiometric matrix of total reactions. The constraints are the outputs of each flux
multiplies each calibrated reaction A G always small than zero. In method 3, the total

outputs are the all species steady state concentrations and all reaction AG of different
modes. Applying these concentrations and AG, and we know the affinity of enzymes and

transporters, we can calculate all rate constants. Eventually, we can calculate the steady
state concentrations and reaction AG, and no need of knowing the rate constants of all
reactions. This means we can decrease the system complexity through decrease the

parameter number, here, rate constants are parameters. Theoretically, we can neglect 2
parameters of each reaction of glycolysis, TCA cycle, and transportation, of each type cell

9

(astrocytes or neurons). The total number of neglected parameters will be different, based

on metabolisms and tissues what we concerned.
After created a simplified model, we are going to try to run the model to output a

reliable dynamic and steady state result, and the result can represent in vivo experimental
data. However, in order to find specific issue, for example, the free radicals which produced
from glycolysis, we need to keep some key steps which cannot neglect in too simplified

model. How to neglect the minor steps and left the key metabolisms? We need to revise in
silico model to represent the concerned issues.

As diets can effectively used to change the level of ketone bodies in blood. We
can use the model to investigate the effect of lipid percentage in diet composition on
metabolic processes in brain tissue. Special attention will be paid to examine the effect of

three important transporters (Complex 1, GLUT, and MCT) in brain tissue metabolism.

10

CHAPTER II
LITERATURE REVIEW

Background
The human brain consists of three main structural entities: the cerebrum, the
cerebellum, and the brain stem (Utsuki, 2015). The functions of these regions such as

cognition, motion, and emotions are coordinated by signal delivery. The brainstem is

formed by midbrain, pons, and medulla oblongata. The term basal ganglia refers to a
functional unit consisting of a series of nuclei, and this structure connects the brainstem

with the cerebral cortex and thalamus.
In order to initiate the movement of the body, the basal ganglia deliver a signal to

the thalamus, and this signal is then transferred to the cerebral cortex and other parts of

brain. The main function of the basal ganglia is to control voluntary movement.
Furthermore, the basal ganglia are involved in high level cognitive functions, for

instance, memory, emotion, and reward learning. Pathological changes in the basal

ganglia will result in the limitation of movement and cognition, and may cause
Parkinson’s disease (PD) as well as Huntington’s disease (LeWitt & Fahn, 2016).

11

The substantia nigra is a nucleus within the midbrain located between the
midbrain tegmentum and the cerebral peduncle. It is not a homogeneous nucleus, and it

can be divided into three regions that differ in structure and functions: substantia nigra
pars compacta, SNpc; substantia nigra pars reticulata, SNpr; and substantia nigra pars

lateralis. Substantia nigra is a subsidiary nucleus of the basal ganglia. Dopaminergic

neurons in the substantia nigra secrete dopamine to the basal ganglia in the cerebrum.
The origin of PD is the dysfunction of the neurons in the substantia nigra. The

neurons in the brain transfer signals via molecules called neurotransmitters. A
neurotransmitter named dopamine, produced by substantia nigra cells, is essential for

normal movement. When the cells in the substantia nigra cell lose functionality,
dopamine is no longer produced or delivered to the basal ganglia, and the transmission of

signals controlling body movement is blocked. Another molecule, called acetylcholine, is
also regulated by dopamine. Insufficient levels of dopamine lead to excessive amounts of
acetylcholine, which induce tremors and muscle stiffness, symptoms frequently present in

patients with PD.

Biochemistry and Brain Metabolism
Normal daily life diet consists of three main types of nutrients: carbohydrates

(60%), lipids (20%), and proteins (20%). The process of digestion transforms
carbohydrates into glucose (Kemppainen et al., 2005). Our brain consumes around 25%

of whole body’s glucose at rest, and 14% during exercise. This change occurs because a
certain amount of glucose is needed to provide energy for the muscles. Neurons use not
only glucose, but also lactate as a fuel. Astrocytes produce lactate from pyruvate and

12

export it to neurons by means of the astrocyte-neuron lactate shuttle (ANLS, cf. Figure
II.1) .

Figure II.3. Brain tissue main metabolic pathways. (Russell et al., 2002)

In neurons, about 10% of pyruvate is derived from glycolysis and 90% from the

lactate shuttle. Lipids are digested into fatty acids in the small intestine and then

transported to the liver. The fatty acids can be converted into ketone bodies, including
acetone, acetoacetate, and BHB (P-hydroxybutyrate). Acetone and acetoacetate are then

metabolized into BHB, and BHB is delivered to the neurons where is metabolized into

acetyl Co-A. Under normal, or standard, diet conditions 65% of acetyl Co-A is derived
from pyruvate, while the remaining 35% is derived from the metabolism of BHB. Acetyl

Co-A, that is produced by metabolizing glucose, lactate, or ketones is then incorporated

into the tricarboxylic acid (TCA) cycle. Brain tissue main metabolic pathways are shown

schematically in Figure II.1.
Glucose as Brain Metabolism Substrate

13

The brain consists mostly of neurons and astrocytes. The function of neurons is

sensing, while astrocytes are supporting cells that provide nutrients to neurons. Glucose

enters the cells through glucose transporters, GLUTs. While each individual astrocyte has
the same glucose transporting rate as a neuron, the number of astrocytes in the brain is
ten times higher than that of neurons. Therefore, the total astrocytic glucose intake is

approximately ten times that of neurons. When glucose enters the cells, it is metabolized

through glycolysis and the TCA cycle, which generates NADH (reduced form of
nicotinamide adenine dinucleotide), ATP (adenosine tri-phosphate), carbon dioxide, and

water.
The glycolysis and TCA cycle are metabolic pathways consisting of more than
twenty metabolic steps. In the process of glycolysis, free radicals, the molecules that

contain an unpaired electron, are produced in the conversion of glyceraldehyde 3phosphate (GADP) to 1,3-bisphosphoglyceric acid (1, 3 BPG) as shown in Figure II.2.
A

14

Figure II.4. (A) Glycolysis and (B) TCA cycle (Salim, 2017).

Antioxidants can decrease free radical concentration by donating an electron to
the unpaired one. If the concentration of free radicals is higher than that of antioxidants,
free radicals will over-oxidize the lipids and proteins on the cell membrane. A high

concentration of denatured proteins can induce cell dysfunction. An important protein
that is susceptible to free radical-induced damage is the complex I protein (NADH

ubiquinone oxidoreductase). This protein uses NADH and transports protons and sodium.

Denaturation of the complex I is believed to induce a loss of neuronal function. If this

happens to the neurons in the substantia nigra, this may potentially cause PD.
Free radicals in brain tissue metabolic phenomena
Glycolysis produces reactive oxygen species (ROS), which contribute to the

oxidative stress, which result in mitochondrial depolarization and ,in turn, progressive
15

neuronal dysfunction (Russell et al., 2002). The accumulation of free radicals generates

oxidative stress (Salim, 2017). When mitochondria produce ATP, ROS and free radicals
appear simultaneously (Pero et al., 1990). Three primary free radicals are hydroxyl
radical (HO^), hydrogen peroxide (H2O2), and superoxide (O2-) (Sanders & Greenamyre,
2013). Even though ROS are needed for neuronal growth, when ROS concentrations
exceed critical levels they have negative effects.

In normal situations, polyphenols can prevent ROS-induced damage during
aerobic metabolism (Adefegha et al., 2016). When the amount of ROS exceeds the action

of antioxidants, this results in an extensive protein oxidation and lipid over-oxidation;

which causes oxidative damage, protein denaturation, and a decrease in cellular function.
High concentrations of ROS decrease synaptic transmission (Knapp & Klann, 2002).

Oxidative stress has a positive feedback mechanism. When the ROS concentration is high
enough to harm the cells by oxidative stress, damaged cells become the sources of ROS.

The brain is susceptible to oxidative stress due to its high content in fat, high
energy requirement, and poor anti-oxidative ability (Hulbert et al., 2007). While

phospholipids are the primary targets, proteins and DNA are also easily damaged by ROS
(Chomyn & Attardi, 2003). Thus, ROS will cause a severe neuronal damage if they

accumulate and surpass or bypass the defense mechanisms (Salim, 2017).
Astrocyte-Neuron Lactate Shuttle

Another important metabolic mechanism in the brain is referred to as the
astrocyte-neuron lactate shuttle (ANLS). It has been hypothesized that ANLS is an

essential pathway for brain tissue to metabolize glucose and a route to sustain neuronal
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activity. The lactate shuttle requires the involvement of MCTs. Under adequate glucose

supply, and by means of astrocyte-neuron lactate shuttle, neurons generate more than
three times the amount of ATP produced in the absence of an active lactate shuttle (Genc

et al., 2011). In the presence of a normal lactate shuttle, but under glucose insufficiency,
neuronal ATP production rate will be only 20% lower than the one reported under
adequate glucose supply and with lactate shuttle activity.

Figure II.5. Neuron-astrocyte lactate shuttle and glutamate-glutamine cycle (Dienel,
2004).

The availability of glucose and lactate in both astrocytes and neurons affects not
only the rate of ATP synthesis, but also mitochondrial levels of these metabolites. While

each astrocyte just contains 1-2 mitochondria, neurons have more than 10-20
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mitochondria. Thus, neurons have larger ATP generation rates than those observed in
astrocytes and have a higher ability to metabolize lactate supplied by the ANLS

mechanism (Genc et al., 2011).

Glutamate-glutamine cycle

Glutamate is an excitatory neurotransmitter that plays an important role in the
TCA cycle. Because neurons do not have glutamine synthetase, these cells cannot
transform glutamate into glutamine. Therefore, glutamate is transferred from neurons to
astrocytes, where it can be metabolized and complete the cycle (Brekke et al., 2015). This

process requires transporters for the release of glutamate from neurons as well for
glutamate to enter astrocytes (Danbolt, 2001). The first step of glutamate-glutamine cycle
begins with a release of glutamine from astrocytes, and its entry into neurons via

absorption by glutamine transporters. Then, the glutamine is catalyzed into glutamate by
phosphate-activated glutaminase, and delivered back to astrocytes. Finally, astrocytic

glutamine synthetase catalyzes glutamate into glutamine (Hogstad et al., 1988; Norenberg
& Martinez-Hernandez, 1979; Varoqui et al., 2000).

Additionally, glutamate is also transformed into a-ketoglutarate that then

participates in the TCA cycle (McKenna et al., 1996). The glutamate-glutamine cycle
controls the concentration of excitatory glutamate by absorption. Astrocytic regulation of

glutamate precursor concentration can diminish the consequences of excitotoxicity by
glutamate (Danbolt, 2001).
Transporters and Complex I
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GLUTs are the proteins located on the cell membrane that transport specific

molecules. GLUT1 in astrocytes and GLUT3 in neurons can transport glucose, 2deoxyglucose, and so on. The Michaelis constant, Km, in Michaelis-Menten kinetics,
represents the affinity between species and transporters. GLUT1 has a Km value 6.9 mM

for 2-deoxyglucose, which is higher than the Km value of GLUT3, ~1.4 mM (Simpson et

al., 2008). However, the affinity of GLUT3 for glucose is five times higher than that of
GLUT1. According to the lactate shuttle hypothesis, lactate provides most energy to

neurons, and it is produced by astrocytes that import much more glucose through GLUT1
than neurons (Simpson et al., 2008).

Monocarboxylate transporters (MCT) transport ketone bodies, pyruvate, and

lactate (Pellerin et al., 2005). There are 14 isoforms (molecules with the same function
but different structures) of MCTs (Halestrap & Meredith, 2004). However, only MCT1 to

MCT4 have been confirmed to co-transport protons and monocarboxylates (Manning Fox

et al., 2000). The transporters differ in their affinity for lactate, so that MCT4, MCT3,
MCT1, and MCT2 have a Km of ~35 mM, ~5.8 mM, ~3.5 mM and ~0.7 mM,

respectively (Pellerin et al., 2005), with MCT2 having the highest affinity (Martin et al.,

2006). In the brain, astrocytes use MCT1 and MCT4 to export lactate, and neurons use
MCT2 to import it.

Four potential models of lactate transfer between astrocytes and neurons by MCTs
have been hypothesized (Pellerin et al., 2005).

•

The first model states that neurons and astrocytes both export lactate while
endothelial cells import it; then, the endothelial cells transform lactate into
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glucose, and glucose is imported into neurons and astrocytes by GLUT3 and
GLUT1 respectively.

•

The second model considers that astrocytic and endothelial cells export lactate,
which is then imported by neurons.

•

The third model considers that only astrocytes export lactate, and that neurons

import it.

•

The last model is states that only astrocytes export lactate, and that neurons

import lactate by synthesizing more MCT2 in situations of high energy demand.
Since the third option has been heavily favored in the literature, we choose that

pathway for the brain tissue model formulation completed in this study.
Complex I is a protein, also called NADH: ubiquinone oxidoreductases type I

(NDH-Is) (Brandt, 2006) that acts as an electron transporter in mitochondria and helps
the transport of protons and sodium ions (Gemperli et al., 2007). The inhibition of the
complex I in the mitochondria in the cells of substantia nigra by an external toxin, for

instance rotenone, might induce PD (Beal, 2003). The effect of modulation of the
complex I activity on ATP production rate was investigated (Zielinski et al., 2016). Due

to complex I act an important role in the cellular metabolism, complex I activity could be

a probe of cell normal function.
Role of free radicals

In general, low concentrations of antioxidant enzymes lead to faster free radical
production and concentrations. The imbalance of intermediate detoxification and repair

20

of damage due to oxidative stress activate systematic reactive oxygen species (ROS)
expression; which leads to the production of per-oxidants and free radicals that damage
protein, lipid, and DNA molecules by interrupting normal redox reactions. Oxidative

stresses resulting from oxidation metabolism results in structural damage to DNA. ROS,

including super-oxidative free radicals, hydroxyl radicals, and peroxide, indirectly induce
structural damage. Furthermore, some reactive oxidants function as intracellular

transmitters in redox signal transmission. As a result, oxidative stress is expected to affect
normal cell signaling (Ojha et al., 2016).
Role of KB transporter

Proton-linked monocarboxylate transporters (MCT) catalyze transport across

plasma membranes of monocarboxylates such as lactate, pyruvate, and ketone bodies
(KB) (acetoacetate, beta-hydroxybutyrate (ßHB), and acetone). One of the requirements
to understand the effect of alternative substrates is to determine the limits of the

contribution of these substrates to brain metabolism.
The transport of lactate between neurons and astrocytes have been studied by

analyzing the dynamics of lactate plasma concentrations after step perturbations of
glucose were introduced to cerebral blood flow (J. C. Lamanna et al., 1992). These

authors correlated their experimental data with a Michaelis-Menten-type functionality
that correlates the plasma-tissue lactate flux (Jb^xc,L) with plasma lactate concentrations

(C[) in the form of the following equation:

Jb ^xc,L

max

K + ('

(1)
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where the maximum transport flux, Tmax, was found to be in the range 0.9-1.4 pmol g-1ww
min-1, and Kt (transport affinity coefficient) ranged between 6 and 12 mM.

It has been reported that, for the baseline (control) PHB plasma levels, the net flux
of PHB across the blood-brain barrier is ~ 0.3 pmol g-1ww min-1. Since the total
tricarboxylic acid flux under standard diet conditions is ~0.72 pmol g-1ww min-1 (~0.57,

79%, in neurons and ~0.15, 21%, in astrocytes) (Shulman et al., 2004), only ~42%
(0.3/0.72) of the fuel required to sustain the metabolism of the TCA cycle could be

provided by ketone bodies. Indeed, there is experimental evidence that the oxidation of
ketone bodies could constitute as much as ~ 53% (0.3/0.57) of the total oxidation of
substrates in neurons. As ketone bodies are present in the extra-cellular space under

normal diet, it can be concluded that the ketone bodies provide the fuel necessary to

sustain 20% of total baseline TCA cycle activity as a baseline condition under normal
diet conditions.

This leads to two important conclusions: (i) ketone bodies, being limited by their

transporters characteristics, can never sustain 100% of the mitochondrial activity; and (ii)

since glucose is the primary energy source for neurons; under conditions in which

glucose influx cannot meet the demands of neurons; an additional substrate is needed to
substitute glucose as energy source.

Hence, the additional fuel required to sustain TCA cycle activity is derived from

the astrocyte and is transported (through the extra-cellular space) via a mechanism called
the “astrocyte-neuron lactate shuttle” (or ANLS). These arguments support the

hypothesis that the astrocyte-neuron lactate shuttle remains active under all cell

conditions.
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Ketogenic diet

Under normal diets, the mitochondria of brain cells will oxidize glucose to fuel

their metabolism. Although the brain represents only 2% of the adult body weight, it
consumes approximately 20% of energy in a static situation. The human brain can
metabolize 120 grams of glucose per day.

Ketone bodies can fuel the brain instead of glucose in cases of glucose
insufficiency; however, the brain can use ketone bodies only if their concentration

exceeds 0.2 mM. Typically, after digesting a dinner and overnight rest, the blood
concentration of ketone bodies is between 0.1 and 0.3 mM. This is often referred to as the
short time high ketone morning symptom. Thereafter, the concentration decreases soon

after eating mixed breakfast, and increases again after completing digestion. The
concentration of ketones bodies in diabetic ketoacidosis conditions exceeds 25 mM

(Shulman et al., 2004).
Compared to the normal diet, ketogenic diets consist in 80% of lipids (fatty acids)
and 20% of carbohydrates and proteins (Adefegha et al., 2016). Low percentage of
carbohydrates results in a decreased availability of glucose in the tissue. In contrast, fatty

acid ingestion leads to the production of ketone bodies in the liver, which can then be

used as substitutes for glucose to fuel cell metabolism. This means that ketone body-

derived energy can be used to maintain normal neuronal function during period of
glucose insufficiency. In other words, under ketogenic diets, ketone bodies become the

main source of energy for brain tissue (Knapp & Klann, 2002). The pathway from fatty

acids to ketone bodies is shown schematically in Figure 4 below.
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Pyruvate

TCA

■ Acetyl CoA

Blood

Figure II.4. Fatty acid metabolized to ketone bodies in liver, then transported to brain
(Knapp & Klann, 2002).
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CHAPTER III
MATHEMATICAL MODEL OF BRAIN TISSUE METABOLISM
Model Overview

This chapter presents the formulation of an in silico mathematical model which
will include the most relevant metabolic pathways. The main metabolic pathways

accounted in this model occur between the following compartments: blood
compartments, extra-cellular space, and cytosol and mitochondria in astrocytes and

neurons. Each compartment includes pathways considered essential, i.e. those associated

with metabolic fluxes directly responsible with deterioration of cell functionality.

Therefore, the model includes the following pathways: glycolysis, TCA cycle, ANLS,
GABA shunt, and glutamine-glutamate cycle as shown schematically in Figure III.1.
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Figure III.1. Neuron-astrocyte lactate shuttle and glutamate-glutamine cycle (Dienel,
2004).
Glycolysis is a ten steps metabolism starting at glucose and ending in pyruvate. Each

glucose molecule will produce two pyruvate molecules and two NADH molecules. The
full glycolysis reactions are listed in appendix I. This pathway, along with the ANLS, is

shown in Figure III.2 below.
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Acetyl-CoA

Figure III.2. Metabolic reactions and fluxes corresponding to glycolysis. Here $ and j
represents flux and species, respectively .

The tricarboxylic acid cycle (TCA) cycle begins from pyruvate through acetylCoA to Oxaloacetic acid (OAA). This cycle includes ten species and 11 reactions (cf.

Figure III.3). The complete list of reactions, fluxes, and species corresponding to the
TCA cycle are tabulated in appendix II.
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A

Figure III.3. (A) Glycolysis and (B) TCA cycle (Salim, 2017).
In addition, these two pathways are assisted by complementary pathways: the

astrocyte-neuron lactate shuttle (ANLS), the GABA shunt, and the glutamine-glutamate

cycle (cf. Figures III.1 to 3).
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The astrocyte-neuron lactate shuttle (ANLS) is the pathway responsible to
transport the lactate produced in astrocytes as fuel to sustain the energy generating

pathway in neurons. This shuttle can supplement the deficiency of pyruvate required to
sustain neuronal metabolism. Indeed, the ANLS-transported lactate is metabolized from

astrocytic pyruvate and the neuronal lactate metabolizes to pyruvate in the neurons.
The GABA shunt is a pathway starting with a -Ketoglutarate ( a KG) through y Aminobutyric acid (GABA) to succinic semialdehyde (SSA). This shunt can bypass
succinyl-CoA. The glutamine-glutamate cycle, glutamate produces glutamine through the

glutamine synthetase in astrocytes, and then the glutamine is transported to neurons and
metabolized to glutamate via the glutaminase. This cycle overcomes the absence of

glutamine synthetase in neurons.
The advantages of a model with this level of complexity are that it enables to
estimate the concentration and flux dynamics for all major species of interest in brain

tissue. However, the disadvantages of a model like this is its dependence on a large
number of parameters; which, more often than not, have a large degree of uncertainty.
Moreover, in models of this dimension it becomes difficult to assess which

species and/or parameters play the most significant role in affecting specific species
levels or flux rates of interest. For instance, if we needed to adjust the extra-cellular

lactate level, we would need to know which parameter will be the most significant in
inducing changes to the lactate level in that compartment. In this type of models, a formal
analysis will yield a large set of parameters, often identifying a different set for dynamic
or steady-state effects. These shortcomings will be illustrated later in this chapter.
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Intra-compartmental dynamic model equations
A number of specific metabolic pathways occur within each cell compartment.
The dynamics of substrate concentrations under isothermal conditions can be described
by simple mass balances as shown in Equation (3). Some species are transported between

compartments and require special attention. Indeed, while most species participate in
metabolic reactions, glucose, lactate, and ketone bodies migrate between compartments.

Thus, for instance the dynamics of glucose in the cytosol (both of neurons and astrocytes)
will be governed by a general equation as shown below in Equation (2)
^ = 0.
- 02 at
1
A (p1,xc)
01
M1+C’1,%c+C’1,c

03 + 04

(2)

(3)

P-(Ac)

02

(4)

M1+C1,Xc+C1,c
^1,^
_1Æ1

03
1+

C1,c | C2,c 1+PS+/ +
'P+
v2-^■ K2

04
1+

PS+/
/^+

C1,c | C2,c

PS

h<

[1+PS-/^--]

(5)

(6)

where C1,c is the concentration of species 1, glucose, in the c, cytosol; 01 is the flux of

glucose transported from xc, extra-cellular space, to c; T1 is maximum transport rate for
mechanism responsible for transporting glucose from extra-cellular space to cytosol; M1

is affinity of glucose of transporter GLUT; 02 is the flux of glucose transporting from c to
b; T2 is transport mechanism rate constant of glucose from cytosol to extra-cellular space;

03 is the flux of glucose metabolize to species 2, G6P; V1 is rate constant of glucose to
G6P; K1 is glucose affinity for HK; K2 is G6P affinity for HK; PS+ = Catp/Cadp ; Catp is

ATP concentration of cytosol; ^+ = ^- is corresponding controller coefficients; 04 is the
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flux of 2 metabolize to 1; PS- = 1/PS+.

03 and 04 are intra-compartmental fluxes, while 01 and 02 are inter-compartmental

fluxes. The corresponding pathways for these fluxes will be discussed later in this
chapter.
The metabolic reaction mechanism for the glycolysis and TCA cycle are detailed

and listed in appendix.

Each intra-compartmental flux will then include 4 parameters, K and V for each of
the two fluxes, which need to be measured, recovered from literature, or calculated. In
each of the cellular metabolic pathways there will be ten glycolytic steps, the ten TCA

cycle steps, the pyruvate-lactate reduction, and the glutamine-glutamate reaction, the
adding reactions and the corresponding parameters as listed below in Table III.1.
Table III.1. Detail of the distribution of fluxes (reactions and/or transport) and the
number of parameters associated with each major intra-compartmental metabolic
pathway.
Cumulative # of

# of Parameters of

Metabolism

# of Reactions

# of Parameters

metabolisms

Compartment

Glycolysis

10

4

40

2

80

TCA cycle

10

2

20

2

40

Pyruvate-lactate

1

4

4

2

8

Glutamine-Glutamate cycle

1

4

4

2

8

GABA shunt

2

2

4

2

Summation

24

72

31

Parameters

8

144

Inter-compartmental Transport Pathways
In addition to the main metabolic reaction mechanisms: glycolysis and TCA cycle

in neurons and astrocytes, there are two additional transport pathways between these two
types of cells that need to be considered: (1) the astrocyte-neuron lactate shuttle (ANLS),
and (2) the glutamate-glutamine cycle. These pathways are essential features in the model

formulated in this research. This study is focused on the role of alternate substrates to
substitute or complement glucose as the primary fuel source for cell metabolism.

The ANLS pathway illustrates the supporting role of astrocytes to maintain

neuronal activity. Indeed, TCA activity in neurons is known to be primarily sustained by
lactate metabolized in the cytosol of neurons. As shown in the schematic in Figure III.1

(and Table III. 1), the total TCA flux under standard diet conditions is ~0.72 pmol g-1ww
min-1, which is partitioned as ~0.57 pmol g-1ww min-1 (79%) in neurons and ~0.15 pmol g1ww

min-1 (21%) in astrocytes (Shulman et al., 2004). The ANLS is also a natural route to

supplement glycolytic activity in neurons and, therefore, a potential mechanism to control
free-radical levels in neurons.
Two inter-compartmental transport mechanisms essential in the ANLS act as

essential steps in this pathway. Glucose transport occurs between blood and the extra
cellular space, and between the extra-cellular space and the cells, ie equation (1) 01 and

02. Pyruvate transport, on the other hand, occurs between the extra-cellular space and
cells, as well as between the cytosol and the mitochondria outer membrane, glutamine or

glutamate transport occurs between the extra-cellular space and cells. Table III.2 below
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shows a summary of the transport processes and parameters involved in inter

compartment transport mechanisms.
Table III.2. Detail of metabolic fluxes and parameters for inter-compartmental metabolic
pathways.
# of Parameters of

Cumulative # of

Transport Process

# of Parameters

metabolisms

Compartment

Glucose

2

2

4

2

8

Lactate

1

2

2

2

4

Pyruvate

1

2

2

2

4

Glutamine or glutamate

1

2

2

2

Summation

5

Transport mechanisms

10

Parameters

4
20

Figures III.1-3 provide schematics of a complete model of brain tissue

metaboilism. It includes glycolysis and TCA cycle metabolic reaction mechanisms and
transport phenomena associated with intra and inter-compartmental fluxes. Tables III.1-2

provide a detail of the parameters associated with this model.
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Flux Balance Analysis

One parameter estimation methodology currently in use involves employing a Flux

Balance Analysis (FBA) (Schilling et al., 2000; Varma & Palsson, 1994) to obtain viable
reaction flux values and thereby reduce the number of unknown parameters in the

metabolic model. The unknown reaction rate parameters of the model are then obtained

by adjusting them in such a way as to correspond to known characteristic times for key

substrates in the metabolic system (Kaliappan, 2006).

The goal of FBA is to solve a system of steady state mass conservation equations

(flux balances) via optimization of a linear objective function, O, that corresponds to a

meaningful pathway objective (e.g. maximization of ATP production), i.e.

NR

O

X ^i,J^J = si 4

(7)

j=1

Here, Vi,j represents the stoichiometric coefficient for reaction “j” of the species “i”(e.g.

ATP) and 4j is the flux corresponding to reaction “j” (si, would denote the i-th row of the
“stoichiometric matrix” S).
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Let us demonstrate some of the shortcoming associated with the FBA methodology by
considering the following example. The system illustrated in Figure III.4 represents a
reaction network with 12 fluxes and 9 species.

$H
r2

r

Boundary

Figure III.4. Sample reaction network

(8)
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For a given nominal input (JA), the system would be not under-determined and it
will have a unique solution. This is often found in the analysis of metabolic pathways where

there will typically be more fluxes than species. The problem can now be solved by
standard linear programming methods. The system of equations presented above,

nevertheless, will have unique solutions.

In the complete model, at steady state, glycolysis flux rate is at a stable level, here

we refer to “stable” as the scenario where all reaction flux rates of glycolysis are the same
(steady-state). If this were in vivo steady state model, the stable flux rate would equal the

cerebral metabolic rate (CMR, 0.58 mM/min), the glucose net transport flux, Typically,

in brain tissue, 85% of the CMR of glucose is considered metabolized in astrocytes, while
the CMR of glucose left is transported to neurons. With this partition of glucose influx to
brain tissue, the FBA problem presented above can be solved both for astrocytes and
neuros, the results are listed in Table III.3 below.
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Table III.3. Detail of the distribution of fluxes (reactions and/or transport) of astrocytes
and neurons.
Flux
Reaction
Flux Rate of
Flux Rate of
Astrocyte(mM/min) Neuron(mM/min)
0.493
0.087
Glc
xc
^
Glc
c
0A
0.493
0.087
Glcc ^ G6Pc
01
02
0.493
0.087
G6Pc ^ F6Pc
03
0.493
0.087
F6Pc ^ F1,6BPc
0.493
0.087
F1,6BPc ^ GADPc
04
0.493
0.087
F1,6BPc ^ DHAPc
05
0.986
0.174
DHAPc ^ GADPc
06
07
0.986
0.174
GADPc ^ 1,3PGc
08
0.986
0.174
1,3PGc ^ Pyrc
09
0.87
-0.87
Pyrc ^ Lacc
0H
0.116
1.044
Pyrc ^ Pyrm
0.87
-0.87
Lacc ^ Lacxc
0,

From the solution, we got the fluxes values of astrocytes and neurons based on

different glucose partition ratio. Figure III.4 presents a simplified schematic of metabolic
fluxes at steady-state, where CMR is clearly connected to glycolytic metabolic fluxes.

The fluxes shown in this schematic are the result of the flux balance analysis (cf. Table
III.3). The substrate partition assumed in the model (Fig. III.5) demonstrates the FBA

results for glucose partitioned between the glial and neuron cells for a reference net flux

value (or cerebral metabolic rate, CMR) of 0.58 u-mol g-1ww min-1 of glucose to brain
tissue for a standard 5 mM plasma glucose concentration.
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Figure III.5. Flux analysis of simplified schematic diagram model.
The largest fraction of glucose is taken up by the astrocyte where it is broken
down to pyruvate and lactate. Lactate, in turn, is transported to the extra-cellular space.

Depending on neuronal demand, lactate is driven from the extra-cellular space to the
cytosol of neuron, where it is converted to pyruvate to fuel neuronal (TCA) activity. A
small fraction of glucose sustains glycolytic activity in the neuronal cytosol, which

complements the lactate-generated pyruvate and completes the supply of fuel (pyruvate)
required by mitochondrial activity in the neuron.

Results reported by Shulman and coworkers (Shulman et al., 2004) suggest a

close interrelationship between neuronal activity, glucose transport, and glycolytic
activity in neurons. According to these authors, the glycolytic path (glucose transporters

activity, or a combined effect) in neurons becomes activated in response to neuronal
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activity. Indeed, glycolytic activity in neurons was reported to follow a linear correlation

with neuronal activity, as indicated by the rate of the glutamate-glutamine cycle.
Closer inspection of the results reported by Hyder and coworkers (Hyder et al.,
2006) indicates that neuronal glycolysis is persistent even at minimal neuronal activity

levels. Their results suggests a baseline glycolytic activity in neurons capable of
sustaining 15% of mitochondrial activity in neurons (0.087 pmol g-1ww min-1 for a

reference value of 0.58 pmol g-1ww min-1 net flux of glucose). Neuronal activity is
responsible for a ~90% of ATP generated from TCA cycle oxidation (Hyder et al., 2006).
Neurons produced ATP is the energy source for clearing glutamate or fueling Na+ pump

of astrocyte (Fernandez-Moncada & Barros, 2014).
With these partitions in mind, FBA shows that approximately 83% of the

pyruvate, required to sustain the neuronal metabolism at steady state, is derived from the
astrocyte-neuron lactate shuttle (Fig. III.4)(Hyder et al., 2006). Glia reserve 10% of net
pyruvate flux for the astrocytic TCA cycle. These reserves include pyruvate
carboxylation, oxidation, and recycling. Thus, Hyder and coworkers analysis clearly

supports the presence of the astrocyte-neuron lactate shuttle (ANLS), complementing
neuronal glycolysis and their functional role under both baseline and neuronal activity
conditions.

Research from Lanz and coworkers (Lanz et al., 2013), due to the fact that neurons

include GABAergic and glutamatergic neurons, if glia were to reserve a larger fraction of
the glucose flux, ANLS will decrease. In a separate work, research by Mangia and

coworkers addressed this issue as well; these authors, however approached incorrectly the
representation for the in vivo neuron-astrocyte lactate shuttle (NALS) by decreasing
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astrocytic glucose transporter (GLUT) activity, which result in a smaller glucose influx
rate (Mangia et al., 2009). Appendix V shows the steady state inter-compartmental
transport fluxes and substrate interaction for standard conditions.
At steady state, the transport of lactate and pyruvate between blood and the extra-cellular

space, as well as that between extra-cellular space and the cytosol, are considered
negligible. In addition, in the control diet, the transport of ketone bodies (BHB and

AcAc) to brain tissue is also neglected. In other words, in the control (or standard) diet, it
is assumed that glucose is the only fuel for brain metabolic activity.

Application of Michaelis-Menten kinetics and Haldane relationship

When examining intra-compartmental dynamic model equations it becomes clear
that four (4) parameters, V1,72, K1, and K2, are required for the characterization of each
net metabolic flux (reaction) in reaction pathways. The enzyme affinity values,

K1 and K2, can be typically found in the literature. The rate constants, V1 and 72, on the
other hand, need often to be determined from measurements. We will use reaction
thermodynamics to reduce the number of unknown (or free) rate constants.
Both dynamic and steady state comparisons between experimental observations

and model predictions can benefit from identifying the critical parameters, or steps, in a
metabolic pathway. Such an analysis can be formalized using a thermodynamic analysis

of the network.
Let’s consider the case of a metabolic reaction in a closed system, i.e.
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For example, in the phosphorylation of G6P to F6P, G6P will be denoted as 1 and F6P as
2 in Eq. (11). If we consider the Haldane relationship:
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One can substitute one of the reaction rate constants as
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The equilibrium constant, Keq, can be defined based on thermodynamics as
If Ke4 = K"e^ = exp(-^-^)

(15)

Where ^"eQ is the further transformed equilibrium constant, and AGf0 is the further
transformed formation Gibbs free energy of specie 1. As a result, although every

metabolic reaction has 4 parameters, only one parameter needs to determined from
indirect measurements.

However, we first need to estimate AG"0 for all species.
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Calculation of the Transformed Gibbs Free energies.
The Gibbs Free Energy of the reactants is a function of temperature (T), ionic
strength (I), and pH, i.e.

G = G (T,I,pH) (16)

The Gibbs Free Energy for any particular species is calculated using the native

thermodynamic data properties data from Alberty (Alberty, 2005). The data consists of a

table for various species at a temperature of 310 K, zero ionic strength, and dilute
aqueous solution. Values of the standard Gibbs free energies of formation (A fG°),
standard enthalpies of formation (Af Ho), the charge number of the species (zt) and the
total number of hydrogen atoms in the species (N (j)) are given for each species at
these conditions. However, to keep the model as close as possible to physiological
conditions AfGo had to be calculated at a pH of 7.4, an ionic strength of 0.25, and a

temperature of 310 K. By specifying the pH, also referred to as first level Gibbs

transformation, the concentration of H+ becomes fixed thus reducing the complexity of
the system as the number of species becomes less. This transformation is achieved by the
equation:

A fG, = A fGoo(I = 0) + Nh (j)RT ln(10)pH -

a(z 2 - N (j))11/2
j
"^----1 +1.61

(17)

Let us consider two reactions from glycolysis and show how the transformed
reaction Gibbs free energies for the species can be calculated at a pH of 7.4, ionic

strength (I) of 0.25, and 310 K temperature. Glucose has the following values ofA Go ,
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Af Ho, z' and NH (i) respectively, [ -915.90 kJ/mol, -1262.19 kJ/mol, 0, 12], units.

Substituting these values in equation (17) , along with the values of I, T, pH and
'o

R(0.00831451 kJ/gmol /K), gives a standard transformed Gibbs Free Energy ( AfGj )

for glucose of 426.71 kJ/mol. Using the data (appendices) the transformed Gibbs Free

Energies for the remainder of the species are calculated. They are summarized in Table
III.4 below.
Table III.4. Transformed Gibbs values at 310 K, 7.4 pH and 0.25 ionic strength.

Species

AfGj (kJ/mol)

Species

AfGj (kJ/mol)

GLC

-426.71

NADH

1120.1

G6P

-1318.8

ATP

-2291.9

F6P

-1315.6

ADP

-1424.2

FCT16P

-2206.7

H2O

-155.66

G3PH

-1095.7

Pi

-1058.6

13BPG

-2206

DHPH

-1088

PHPYR

-1189.4

2PHG

-1346.8

PYR

-350.78

3PHG

-1340.6

LAC

-313.7

NAD

1059.1

‘

so o

'

so o

Where GLC denotes glucose, ATP is adenosine triphosphate, G6P is glucose 6-phosphate,
ADP is adenosine diphosphate, G6P is glucose 6-phosphate, F6P is fructose 6-phosphate,
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FCT16P is fructose 1, 6-biphosphate, G3PH is glyceradehyde 3-phopshate, NAD is
oxidized nicotinamide adenine dinucleotide, DHPH is dihydroxyacetone phosphate,
NADH is reduced nicotinamide adenine dinucleotide, Pi is phosphate, 13BPG is 1, 3-

biphosphoglycerate, 3PHG is 3-phosphoglycerate, 2PHG is 2 phosphoglycerate, PHPYR

is phosphoenolpyruvate, PYR is pyruvate and Lac is lactate.
Calculation of the Further Transformed Gibbs Free Energy

Some of the possible simplifications include specifications for the concentrations

of some of the species. For example, it is possible to assume a fixed proton
concentration, hence fixed pH. To account for this specification while still maintaining

the thermodynamic information of the chemical reactions involved in these species, a

Legendre transformation of the Gibbs Free Energy is used. The general equation for this

is,

G = G - Z n. (Ai)V(A,)

(18)

Where, nc (Ai) is the number of times species Ai appears in the reaction, and ^(Ai) is

its chemical potential. In the model, the concentrations of the coenzymes NAD, NADH,

ATP, ADP, and Pi are considered constant for the sake of simplicity. The effect of the
coenzymes concentrations on the systems equilibrium composition is analyzed later in

this section. Table III.5 below lists the nc values of each coenzyme for all the species

involved in the pathway.
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Table III.5. nc Values of the different species in the pathway.
G6P

F6P

FBP

DHAP GAP BPG

3PG

2PG

PEP

PYR LAC

ATP

1

1

2

1

1

1

0

0

0

-1

-1

ADP

-1

-1

-2

-1

-1

-1

0

0

0

1

1

NADox

0

0

0

0

0

1

1

1

1

1

0

NADred

0

0

0

0

0

-1

-1

-1

-1

-1

0

Pi

0

0

0

0

0

1

1

1

1

1

1

The following specified coenzyme concentrations ATP = 2.36, ADP = 0.91, NAD = 1.05,
NADH = 0.2, and Pi = 0.24, expressed in mM. These concentrations correspond to

astrocytes, and were taken from the literature (Williams et al., 1980; Xie et al., 2009).

The further Transformed Gibbs Free Energy can now be calculated. Table III.6 below
summarizes these values.

Table III.6. Further transformed Gibbs free energy values at specified coenzymes
concentration.

&fG"0

Species
GLC

-426.71

G6P

-453.48

F6P

-450.34

FCT16P

-476.15

DHPH

-230.39

GADP

-222.73

13BPG

-225.5

3PHG

-231.5

2PHG

-225.34

PEP

-74.145

PYR

-100.8

LAC

-122.55
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In summary, we can use the standard Gibbs Free Energy of formation for each

species, and then estimate the further Transformed Gibbs Free Energy through the
approach formulated by Alberty (Alberty, 2005; Zimmerman, 2003).

The table for the Gibbs Free Energy for the reactions in the glycolysis for astrocytes are

shown below along with the corresponding equilibrium constants.
Table III.7. Further transformed reaction Gibbs Free Energy (kJ/mole) for Glycolysis in
Astrocytes.
__________________________________________
Astrocytes
Source
Product
G6P
-26.77
Glucose
G6P
F6P
3.14
F6P
F1,6BP
-25.81
F1,6BP
GAP
253.42
DHAP
GAP
7.66
GAP
-2.77
1,3PG
3PG
-6
1,3PG
3PG
2PG
6.16
2PG
PEP
151.195
PEP
-26.655
Pyruvate
21.75
Lactate
Pyruvate

A complete detail of the reaction Gibbs Free Energy krG"°, equilibrium constant Keq,

rate constants V and affinity constants K for the glycolysis and TCA cycle both in
astrocytes and neurons are listed Appendix V.
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CHAPTER IV

MODEL VALIDATION
In chapter III, a mathematical model of brain tissue metabolism was formulated.

We would like to use this model to predict potential responses to stimuli and or changes

in metabolism resulting from diet changes. Before applying this model for prediction or
detailed assessment of metabolic fluxes, however, we need to ensure this model is
reliable. In other words, the model needs to be validated to ensure it can be used to study

real-world physiological metabolisms. The meaning of validation is comparing the results
of mathematical model with the corresponding experimental results, both qualitatively
and quantitatively (Volland et al., 2017). In our model, which includes glycolysis, TCA
cycle, ANLS, and glutamine-glutamate cycle. We can select some condition to validate
our model, for instance, comparing reaction fluxes rate and species concentrations. For

reaction fluxes rate, we need to know reaction equations and parameters. For species
concentrations, we need measure the level of species. For the monitoring (or tracing) of

the concentrations of species participating in the glycolysis (in cytosol) and TCA cycle

(in mitochondria), traditional detecting method rely on NMR (Nuclear Magnetic
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Resonance) to measure the labeled 13C species in each step of the metabolic reactions
(Brand et al., 1992; Campbell-Burk et al., 1987; Mackenzie et al., 1984). However, for
ANLS and glutamine-glutamate cycle, some studies in the literature report on the lactate,
glutamine, or glutamate levels in the extra-cellular space (Hu & Wilson, 1997; Lacreuse

et al., 2018).
Since free radicals have been identified as the root cause for certain brain diseases
(LeWitt & Fahn, 2016). The model formulated in this dissertation is focused on the
glycolysis flux rate, as it might affect the free radicals production rate. The glycolysis

metabolic rate has relationship with ANLS and expressing dynamic oscillations in the

extra-cellular space lactate levels (Hu & Wilson, 1997).

A wealth of literature data can be found on brain metabolism. These experimental

studies address a variety of issues in brain tissue metabolism. Lactate has been identified
as an efficient substrate in neurons. Indeed, lactate not only supports respiration but also

maintains ATP levels during intense levels of activation (Pellerin et al., 1998). In the

early 1990’s, Pellerin and Magistretti suggested a relationship that established tight
coupling between neuronal activity and energy metabolism (Pellerin & Magistretti,

1994). They identified a strong balance between synaptic glutamate release and its
reuptake into astrocytes that triggers aerobic glycolysis in the astrocytes and produces
lactate. These authors stated that, contrary to the classical hypothesis (Maher et al., 1994),
lactate is shuttled to the neuron through the mechanism which they termed the Astrocyte

Neuron Lactate Shuttle, or ANLS (Magistretti & Pellerin, 1999). More recently,

Magistretti presented evidence highlighting strong astrocyte-neuron cooperation to deal

with high energy demands of neurons, which suggest that under certain circumstances
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neuronal demands will be satisfied by lactate produced in astrocytes (Magistretti &

Allaman, 2018). Dienel’s recent research shows that astrocytes produce lactate by
metabolizing glucose and glycogen (Dienel, 2019). Barros and Weber issue that ANLS

has connection with neuron activity (Barros & Weber, 2018). Since the astrocytes
number is 10 times that of neurons, glucose will be metabolized primarily by astrocytes
instead of neurons, and produce high levels of pyruvate in astrocytes’ cytosol. High
levels of pyruvate in astrocytes will drive the production of lactate, which, in turn, is then
transported to the extracellular space and subsequently to neurons, where is metabolized

into pyruvate. The pyruvate concentration gradient is the driving force induces different

equilibrium between lactate and pyruvate between the neurons and astrocytes. It has been
proposed that the lactate transport from the astrocyte to the neuron is based on a demand

based regulatory mechanism. This theory not only unified coupling between brain
activity and the astrocytic and neuronal metabolisms, but also proved to be an important
breakthrough in the metabolic modeling of the brain.

This theory received mixed reactions, including strong criticisms (Chih et al.,
2001) that challenged the ANLS. However, most of these publications did not show

experimental data to support their theories. Studies were done to further this claim of
lactate being the preferential substrate of the neurons and it was shown that when neurons

were incubated in media containing glucose and lactate separately, the relative

contribution of lactate towards neuronal oxidation was higher (Bouzier-Sore et al.,
2003).This implies that lactate can enter both neurons and astrocytes, but lactate is

preferentially metabolized in neurons.
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To understand the metabolite dynamics that are directly associated with brain

energetics, some researchers developed models that would attempt to understand the

various (metabolic, hemodynamic and electrophysiological) aspects of the brain. Aubert
and coworkers (Aubert et al., 2002), for instance, formulated a model based on

differential equations derived from mass balances to simulate the dynamics of glycolytic
fluxes and oxygen exchanges. This group then investigated the ANLS hypothesis from a

theoretical view by developing a compartmental model and testing it with external stimuli

(Aubert & Costalat, 2005). Simulations of the brain stimuli were performed and the flux

of lactate in the sub and extra-cellular compartments was studied. A continuous flux of
lactate was seen from the astrocyte to the neuron during basal and excited states,

consistent with the ANLS theory. The authors further suggested that the classical and the
ANLS theories do not contradict each other; rather they seem to work concomitantly
towards explaining the mechanism of metabolism. These authors also studied the

dynamic behavior of the neuron in the presence of electrical stimuli. Such an study was

based on experimental data gathered by Hu and Wilson (Hu & Wilson, 1997). Hu used

electrical stimulus to induce increased neuron uptake of lactate. The experimental study
measured the fluctuations in extracellular lactate levels in the brain in response to acute

neuronal stimulation. An initial dip in the concentration of lactate in the extra-cellular
space was observed at the beginning of each stimulus.

While Newman and coworkers demonstrated that a test where mice were put to
negotiate a maze, associated with neuronal stimulation, also induced increased neuron

uptake of lactate , Newman’s test (Newman et al., 2011), however, did not indicate any

initial dip of lactate levels in extra-cellular space.
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Aubert’s group focused their attention on the understanding of the mechanisms
leading to an initial “dip” and subsequent increase in tissue lactate levels during sustained

and periodic stimulation. These authors formulated a model capable of reproducing this
phenomenon by defining an ad-hoc input function that incorporated parameters

accounting specifically for factors that may influence the extra-cellular lactate kinetics
such as the intra-cellular lactate and pH variation. This function successfully reproduced

the effect caused by the sensors used in Hu and Wilson’s experiments to stimulate the
brain (Hu & Wilson, 1997).

The initial dynamics of lactate have been studied by other authors (Mangia et al.,

2009), who used proton magnetic resonance spectroscopy to understand neuronal
energetics during functional activation. They found an initial dip decrease in the lactate

concentration during the early phase of neural activation, which could be explained by
the increased lactate consumption following neural activation.

These observations led us to the following questions. Is neuronal metabolism

primarily oxidative and glial metabolism primarily glycolytic? What is the substrate
partitioning of glucose and lactate between the astrocytes and the neurons?

The aim of this work was to combine various modeling efforts and expand on the

current modeling strategies reported in literature. Data collected from physiological
experiments were used to formulate and validate the model. A multi-domain model that
distinguishes between the cytosol and the mitochondria, both in neurons and astrocytes, is

presented in this dissertation. The model includes a detailed model pathway emphasizing

the role of alternate energy substrates, such as ketone bodies, known to participate in the
brain energetics (cf. Fig. IV.1).
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Figure IV.6. Flux analysis of simplified schematic diagram model.

Ketone body metabolism has been thought to affect glucose metabolism by
altering carbon fluxes originating from glycolytic activity (neuron and astrocyte). This
has been hypothesized to occur through the partitioning of carbon units away from
glycolysis and towards the TCA cycle at the level of Acetyl-CoA as shown in the

schematic of Fig. IV.2.
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A

Figure IV.7. (A) Glycolysis and (B) TCA cycle (Salim, 2017).

Experimental studies available in the literature, present data in many different
forms, such as fluxes, species levels and concentrations, and dynamic responses to

different perturbations, among others. The connection with a mathematical model like the
53

one proposed in this study and the relevance of these observations to lead the model

formulation and development, as well as assisting in its validation, present a number of
issues.

In a typical study on neuronal activation, Hu and Wilson (Hu & Wilson, 1997)

applied electrical stimulation to rats. These authors monitored the dynamics of lactate
concentration in the extracellular space of hippocampus following a single electrical
stimulus as well as the results for multiple (cyclic) electrical stimuli. Let us examine
those two illustrative scenarios.

Lactate dynamics following neuronal activation experiments
In this section, results are compared to experimental data (Hu & Wilson, 1997)

followed by the model predictions under conditions corresponding to a single electrical
stimulus for rats subject to standard diet.

In vivo experimental data (Hu & Wilson, 1997) of the lactate dynamics induced
by a single electrical stimulus and the two models, along with the percent deviations, are
presented in figure 8 lactate concentration change during electrical stimulus.

These experimental results indicate a significant (~ 70% relative to the baseline

levels) increase in the extra-cellular lactate levels. Figure IV3 below shows the tissue
lactate dynamics following a single neuronal stimulation. A 5-s electrical stimulus

induces an initial drop of the CMR for 18s, followed by a sharp increase in lactate

concentration levels, peaking after 70-s following the stimulus, the dynamics is

completed by a period of recovery showing an exponential decrease during which lactate
levels return to those corresponding to the pre-stimulus conditions.
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Figure IV.8. Lactate concentration (%) for single-stimulus experiment (figures are made
in (Hu & Wilson, 1997)).
We can illustrate the potential and difficulties associated with the use of this type

of data to validate a more complex model, as the one formulated in this work. In the
following sections the performance of simplified (Aubert et al., 2005) and complex (this
work) models are compared with Hu and Wilson (Hu & Wilson, 1997) experimental

measurements of lactate concentration in the extra-cellular space during neuronal

activation induced by a single and multiple electrical stimuli experiments.

Using Dynamic Data for Model Validation
Aubert and coworkers (Aubert et al., 2005) formulated a simplified model to
mimic brain metabolism under neuronal stimulation. The model simulated lactate levels

in the extra-cellular space following perturbations to the fluxes through the blood-brain

barrier, and in the capillaries network irrigating the brain.
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This model was a simple mathematical model of lactate concentration dynamics

induced by perturbations to the extra-cellular space lactate concentration. The authors
concentrated their attention on the lactate transport mechanism between capillary, blood
brain barrier, and brain tissue, but they did not consider the physiological metabolism of
glycolysis and pyruvate-lactate redox reactions. The model contained only 19 parameters

and 11 equations, and the model could qualitatively and quantitatively reproduce the
lactate dynamics observed experimentally for single electrical stimulus as reported by Hu

and Wilson (Hu & Wilson, 1997). However, although Aubert’s model could reproduce
qualitatively the experimental dynamics for multi electrical stimuli, the quantitative

agreement with experimental measurements was very poor in this latter scenario.

Indeed, the results for a single electrical stimulus were very close to experimental
observations, resulting in a coefficient of determination of approximately 92%
(R2=0.917). For multiple electrical stimuli scenario, on the other hand, the simulated

results resulted only in a coefficient of determination of 45% ( R2=0.4512). Figure IV.4
shows the comparison between simulations of extra-cellular lactate concentration

dynamics induced by multiple step perturbations to lactate influx to tissue (Aubert et al.,
2005) with in vivo experimental data (Hu & Wilson, 1997).
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Figure IV.9. Comparison between flux-induced extra-cellular lactate dynamics (red
crosses (Aubert et al., 2005)) with in vivo experimental data resulting from neuronal
activation by electrical stimuli (blue circles (Hu & Wilson, 1997)).
(A) Single electrical stimulus and (B) Multi electrical stimuli.

As shown above, poor quantitative agreement was reported in Aubert’s research
and lactate levels in extra-cellular space observed experimentally for multi electrical
stimuli. This suggests that some of the model parameters need to be adjusted. Since our

research model and Aubert’s model differ in the degree of complexity, one needs to focus
the attention on those parameters common to both models.

We first followed Aubert’s (Aubert et al., 2005) approach to mimic extra-cellular
lactate dynamics during neuronal activation experiments.

How to ensure that our model could be compared with Aubert’s model? Our
model includes glycolysis, TCA cycle, ANLS, and glutamine-glutamate cycle. ANLS
includes the lactate fluxes between astrocytes, neurons, extra-cellular space, and blood.

Aubert’s group used 11 equations and 19 parameters to describe lactate fluxes between

blood and extra-cellular space. We take these 11 equations and 19 parameters and apply
those equations and parameters in ANLS of our model. Among our model 164

parameters, 19 parameter values come from Aubert’s model, while the remaining 145

57

parameters were adapted from the literature. I will refer to this model as the Chan-Aubert

model.
Extra-cellular lactate levels dynamics was induced by perturbations to the lactate

fluxes between capillary and extra-cellular space of brain tissue in our 164 parameters

model, trying to replicate observations reported during single and multi electrical stimuli.
The results are shown below in Figure IV.5. The simulation results found with this

adapted, or Chan-Aubert’s, model showed acceptable qualitative agreement, but
quantitative agreement was very poor, both for the single and multiple perturbation

exercises.

time, s

Figure IV.10. Comparison between extra-cellular lactate concentration flux-induced
dynamics (red crosses, Chain-Aubert’s model) with in vivo experimental observations
during neuronal activation induced by electrical stimuli (blue circles (Hu & Wilson,
1997)).
(A) Single electrical stimulus and (B) Multi electrical stimuli.
This lack of quantitative agreement was observed when the model used the 19

parameters from Aubert’s group. That clearly suggests that the 164 parameters model

may be better adjusted by changing a different set of parameters. However, how does the
change of these different parameters affect the dynamics of other substrates, for which
dynamic data is not available for comparison. These questions obviously need to be
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answered before considering the validation exercise successful. In other words, if we

want to use Hu and Wilson’s (1997) data to validate our model, we need first to find a
different method to test (validate) the model.
Two of the 164 parameters in our research model are the cerebral metabolic rate

(CMR) and blood flow rate. CMR represents the brain energy consumption rate and

blood flow rate will change accordingly to meet the glucose demand associated with a
given CMR. Under rest and standard diet conditions, brain energy demands are supported
by the metabolism of glucose. Therefore, CMR also represents the net glucose influx to
brain tissue.

In a recent modeling effort, Patel and coworkers (Patel et al., 2004), concentrated

their attention in some of the inter-compartment (cells) pathways in the glycolysis and the
TCA cycle, particularly glutamate-glutamine cycle and GABA shunt, but simplified the
basic intra-compartment pathways. This group studied tissue metabolic dynamics for
glucose as the main energy substrate. One of the salient features of this study consisted in
using CMR to represent glucose consumption. The model formulated by Patel and

coworkers consisted of 18 (mass balance) equations and 70 parameters for a simplified
brain tissue model. The model could successfully reproduce experimental measurements

of the dynamic enrichment of glutamate and aspartate (Patel et al., 2004).
Now, the 164 completed model, 19 parameters come from Aubert’s group, and we
adjust the CMR and blood flow rate terms by the Patel’s method in Chan-Aubert model.

This model will now be referred to as the Chan-Aubert-Patel (CAP) model. In this model,

neuronal stimulation experiments were mimicked by using CMR dynamics to represent
glucose influx changes and blood flow rate changes induced by electrical stimuli. Hu and
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Wilson’s data (Hu & Wilson, 1997) included glucose dynamic percentage levels both for

single and multiple electrical stimuli experiments. Therefore, CMR dynamics can be
easily back-calculated based on the net glucose influx to brain tissue in single and multi

electrical stimuli scenarios.
In the CAP model, glucose is metabolized to pyruvate by glycolysis, and pyruvate
can be reduced to lactate, then lactate can transported between the cells and the extra
cellular space. The dynamics of lactate concentration levels in the extra cellular space can

now be compared to the experimental results reported by Hu and Wilson’s research (Hu
& Wilson, 1997) as shown in Figures IV.6 and 7 below.

Figure IV.11. Lactate concentration dynamics in the extra-cellular space following a
single electrical stimulus of 5-s and recovering peaks at 2 min to 170% of the baseline
(pre-stimulus levels at t = 0: min).
Model predictions vs. experimental data (adapted from (Hu & Wilson, 1997))

Figure IV.7 below shows the dynamic response in lactate concentration in the
cytosol of the neuron during a sequence of 10 stimuli. Each stimulus consisted of a

stimulation period of 5-s followed by a rest interval of 2 min. Lactate levels reached a
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maximum of ~70% increase from its baseline values during the activated period. The
agreement with the experimental determinations reported in the literature (Hu & Wilson,

1997) showed now a remarkable improvement as evidenced by coefficients of
determination larger than 98%, both for a single (R2 = 0.9872) and multiple (R2 = 0.9876)

electrical stimuli.

Figure IV.12. Dynamic response in lactate concentration (normalized) during a sequence
of 10 repeated stimuli: 5-s stimulus followed by a 2 min rest interval.
Model predictions vs. experimental data (adapted from (Hu & Wilson, 1997)).
These two examples illustrate the relationship between model parameters and

predictions, and how the comparison between in vivo and in silico can be used to
adjust/validate the mathematical model.
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In summary, CAP model improves the qualitative and quantitative agreement

between experiments and model predictions. However, discrepancies provided valuable

insight into the deficiencies of the model at each of its formulation stages. Table IV.1
summarizes the similarities and differences among the different models.

Table IV.8. Models Comparison Summary.

Model

Salient features

Hu

Electrical stimulus and CMR in vivo experiment (Hu & Wilson,
1997).

Aubert

19 parameters lactate transport mechanism model. Lactate

injection from blood to tissue.

.
_y
1 CLac,EC
JLac_BBB ‘max 1 ¡r . yAt + cLac,EC
hac_Biood

and

hacrissue

CLac,Blood
\
\ r
I
^t + cLac,Blood/

1/

are defined in Aubert’s literature

(Aubert & Costalat, 2005).

Chan-Aubert

Combined 145 parameters model of glycolysis, TCA cycle,

ANLS, glutamine-glutamine cycle, and 19 parameters model of
lactate injection from Aubert’s model, total is a 164 parameters

model.

Patel

70 parameters model with CMR represents glucose level (the

others include pyruvate-lactate redox, TCA cycle, glutamate

glutamine cycle). The CMR will change with glucose oxidative
rate change in neurons and astrocytes (Patel et al., 2004).
CMRgic

total

=

CMRGlc ox Neuron

+

CMRGlc ox Astrocyte

Chan-Aubert-

Combined 143 parameters model of glycolysis, TCA cycle,

Patel (CAP)

ANLS, glutamine-glutamine cycle, 19 parameters model of
Aubert’s model, and 2 parameters model of CMR and blood flow
rate, total is 164 parameters model.
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°CGic_Tissue)

K is diffusion coefficient, which will change with blood flow rate,
and a is partition ratio of glucose transports to neurons or

astrocytes.

Indeed, under the single electrical stimulus, the lactate concentration increased
rapidly following the electrical stimulus, reaching a peak of approximately 180% of the
steady state condition, and then decreased slowly back to the steady state condition

before the electrical stimulus. Although, the simulation results match the experimental
data with R2 close to 1, one can see that the flux dynamics needs further attention. The

high-level CAP model (with 164 parameters and 54 mass balances) can reliably predict
the dynamics of the fluxes associated with lactate concentration under neuronal activation
conditions without adjusting and model parameters.

The model will next be used to examine dynamic responses under diets that will

result in ketone bodies complementing glucose as the main fuel (substrate) to sustain
brain energetic demands.
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CHAPTER V

MODEL EXPANSION: KETOGENIC DIET
In chapter IV, we validated the CAP model, which includes several pathways: (i)

glycolysis, (ii) TCA cycle, (iii) the ANLS, (iv) the glutamate-glutamine cycle, and (v) the
GABA shunt. The CAP model proved to be reliable to model the extra-cellular lactate

dynamics during electrical stimuli in control (or standard) diets. In this research,

however, we would like to study the effects of ketogenic diets (KD on the neuronal
glycolytic metabolism. In ketogenic diets (KD), ketone bodies include pHydroxybutyrate (PHB), acetoacetate and acetone. Acetoacetate and acetone will

metabolize to pHB in liver, and pHB will be transport to brain tissue as an energy fuel. In
order to consider the effect of KD, we need add some additional reactions and transport
mechanisms in the CAP model. The KD-related reactions and transport mechanism are
listed in Table V.1. We will refer to the expanded model as the Chan-Aubert-Patel-

Ketogenic (CAPK) model.
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Table V.9. Reactions involving ketone bodies and required parameters (A) Metabolism
and (B) Transport mechanism.

A
Parameter
Number

Source

Product

ßHB

Acetyl-CoA 4

Acetyl-CoA

Glutamate

4

B

Species

From

To

Parameter
Number

ßHB

Blood

Extra-cellular

4

ßHB

Extra-cellular Cytosol (A & N) 8

The expanded CAP, or CAPK, model includes the flux of ketones as a
complementary or alternate substrate to sustain energetic demands in neuros. The

question that remains unanswered is what portion of the flux of ketone bodies (^HB and
acetoacetate) will metabolize to acetyl-CoA. There is experimental evidence that states
that the oxidation of ketone bodies could support as much as ~ 60% of the total oxidation

(Siesjo, 1979). This leads to two important conclusions: (i) ketone bodies, being limited
by their transport characteristics, can never sustain 100% of the mitochondrial activity,

and (ii) there is always a need for an additional influx to the TCA cycle apart from that

provided by the glycolysis in the neuron. This is because the glycolysis in the neuron is
directly related to the activity levels of neuron and, alone, it would not be sufficient to
meet the demands of the neuron (Shulman et al., 2004). Hence, the additional fuel

required to sustain the Krebs cycle activity is derived from glycolytic activity in
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astrocytes, and is transported to neurons (via the extra-cellular space) through the

mechanism referred to as the “astrocyte-neuron lactate shuttle” (ANLS). These
arguments support the hypothesis that under all conditions, the astrocyte-neuron lactate

shuttle remains active. Ketosis cannot increase unlimited to replace the brain glucose
demand.

We will assume 80% lipid diet just produce 0.24 mM/min net flux of pHB
metabolize to acetyl-CoA. 0.24 mM/min pHB metabolic flux is about 23% of neuronal

TCA cycle flux (1.044 mM/min). pHB come the ketone bodies which produced by lipid
metabolism in liver. Why ketogenic diet with 80% lipid and 20% protein plus

carbohydrate just occupied 23% neuronal TCA cycle? Because some lipid will metabolic
to fatty acid and glycerin for storage, and some lipid will metabolize to glucose for

energy demand, the left will produce ketone bodies. The most ketone bodies will
metabolize to pHB. Then pHB transports to brain, diffuses to extra-cellular space,

transport to neuronal cytosol, due to the limitation number of MCT (Monocarboxylate

transporters), only 23%, 0.24 mM/min flux shows in pHB^acetyl-CoA reaction. 0.24
mM/min is the maximum pHB^acetyl-CoA metallic rate, and even higher lipid
percentage (> 80%) of ketogenic diet will not contribute any extra pHB^acetyl-CoA
metabolic rate. Higher than 80% ketogenic diet is unreasonable, and out of our model

design. Then we compare the flux rate of pHB^acetyl-CoA reaction and ANLS, 0.24
mM/min vs. 0.87 mM/min, even the maximum pHB^acetyl-CoA reaction rate is not
high enough to reverse ANLS direction.

66

A net plasma-to-tissue influx of 0.58 pmol g-1ww min-1 of glucose (or CMR) is

used as a reference in this study for the baseline condition (i.e., standard or control diet

conditions).
Shulman and coworkers reported that the total (neuron and astrocyte)
tricarboxylic acid flux can vary between 1.0 to 1.6 pmol g-1ww min-1 (Shulman et al.,

2004). Therefore, a value of 0.24 pmol g-1ww min-1, considered as the maximum net
ketone influx to neurons in the CAPK model, could sustain as much as ~20% of the TCA

activity at steady-state in ketogenic diet.

In the CAP and CAPK models, both standard and ketotic diets will reserve a
portion of the CMR to sustain a 10% TCA activity in astrocytes. TCA activity includes
pyruvate oxidation to acetyl-CoA as well as pyruvate carboxylation to OAA. If we

calculate the astrocytic pyruvate oxidation only based on the total pyruvate neuronal and
astrocyte oxidation (TCA activity deduct pyruvate carboxylation), the contribution of the

astrocytic pyruvate oxidation will increase. This increased contribution will depend on
how much of pyruvate carboxylation. In other words, the tricarboxylic acid flux of

neurons and astrocytes under standard diet conditions would correspond to 1.16 pmol g1ww

min-1, which is partitioned as 1.044 and 0.116 pmol g-1ww min-1 for neurons and

astrocytes, respectively.

Under ketogenic diet conditions, neuronal and astrocytic TCA cycle fluxes are
assumed to remain at the same levels shown for standard diets. The net glucose influx

under ketotic conditions, however, decreases as the fuel influx is partially sustained by
ketone bodies. Lactate transport parameters are kept constant and as reported by
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LaManna and coworkers (J.C. LaManna et al., 1992). Figure V.1 presents a simplified
schematic diagram of fluxes in the CAPK model.

Figure V.13. Flux analysis of simplified schematic diagram of CAPK model.

Determination of substrate Steady-State levels by Optimization

This section consists in determining the steady-state substrate levels under

ketogenic diets. The method applied here is based on the research reported by Beard and
Qian (2005) (Beard & Qian, 2005). These authors proposed to minimize the total Gibb’s

free energy based on the enzyme activity. This approach is based on the fluxes (transport

and kinetics) and steady state species concentrations for the CAP and CAPK models.
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Beard and Qian’s approach consisted in defining the enzyme activity as follows:
e

AGj'(C)-AGj‘0
RT
)
.\G’' C

1-e

(19)

kt

Where Ct,j is total concentration ofjth reaction, C is concentration vector of reactants, fy

is flux ofjth reaction, ^Gj' and &Gj'° are the vectors ofjth reaction further transformed
Gibb’s free energy under steady-state and equilibrium condition, respectively. The
researchers defined Ct as
C, = nacc,)»1 + H"

(20)

1C.)-

Here C. expresses ith species concentration, Ns represents number of species, a and ft are

stoichiometric coefficients of the forward and backward reactions, respectively.
Then we can define AG for an open system. The Gibb’s free energy can be represented

as:
M" = &G"° - RTSTlnC

(21)

Where ST is transpose of the stoichiometric matrix (i.e., excluding the influx and out-flux

of system).

The first set of constraints are formulated as follows
i „cND = i
„cKD
LnullC
LnullC

(22)

LnuuXcS^ = 0

(23)

Where Lnull is left null space of XcS, and Xc is a diagonal matrix, which represents the

species distribution between cytosol and mitochondria, S is stoichiometric matrix of the
system, 0 is flux vector,

CWD and

C™ are species concentration vector under normal

(ND) and ketogenic (KD) diets conditions, respectively.
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Based on the second law of thermodynamics, a constraint on the fluxes can be

formulated: namely the metabolic fluxes combined with the change in Gibbs’ free energy
for each reaction must meet the condition
fy • Mj' < 0

(24)

In an earlier chapter (Chapter IV), we showed how to calculate the steady-state

(and dynamic) species concentrations of ND. By Beard and Qian’s (Beard & Qian, 2005)
method, we can calculate the steady-state species concentrations of KD.
Indeed, the CPA model was validated and it can therefore be used to find the steady-state
conditions (concentration levels) for the ND. The CPA model included, not only the

steady-state concentration levels of all the species involved, but all the associated kinetic

and transport parameters.
These values can be used to find the Enzyme Activity as defined by Equation
(19). Table V.2 below, lists the enzyme activities, the Gibbs free energy changes, and the
metabolic fluxes for the glycolysis in astrocytes and neurons under ND conditions.

Table V.10. Enzyme activities, Gibbs free energy changes, and metabolic fluxes for in
the cytosol of astrocytes and neurons under ND conditions.

Normal Diet

Enzyme Activity

AG

Reaction

Astrocyte Neuron

Astrocyte Neuron Astrocyte Neuron

Glc to G6P

1.38E-01

1.14E-03 -8.553

-25.857 0.493

0.087

G6P to F6P

2.78E-01

1.09E-02 -10.933

2.331

0.493

0.087

F6P to FDP

1.90E-02

3.38E-03

-28.842 0.493

0.087

FDP to GAP+DHAP

9.81E-02

1.42E-02 -5.62

24.916

0.493

0.087

DHAP to GAP

5.87E-02

7.81E-03

-6.181

0.493

0.087

GAP to 13PG

3.92E-02

4.71E-04 -14.377

8.222

0.986

0.174

13PG to 3PG

2.37E+32 5.45E+32 -12.473

-19.318 0.986

0.174

70

-16.313

-8.897

Flux

3PG to 2PG

2.88E-01

2.39E-02 -15.385

11.921

0.986

0.174

2PG to PEP

3.23E-01

1.21E-02 -8.472

150.567 0.986

0.174

PEP to PYR

6.49E+34 1.60E+34 -19.1

-22.609 0.986

0.174

LAC to PYR

-1.37E-02 1.41E-01

-6.362

-18.342 -0.87

0.87

PYR to AcCoA

1.66E-02

-20

-447.273 0.116

1.044

1.66E-01

One can easily see that a minimum in objective functions, as defined by Equation (25)
will be achieved if the enzyme activity remained the same under ND and KD conditions.

Therefore, the enzyme activity, along with a flux balance analysis of the KD (Table V.3),
can be used to find the steady-state concentration levels under KD conditions (Table
V.4).
(eND_eKD\2

yNr (EJ EJ )
j=1 max(E^D,EfD)2

(25)

Where Ct,j is total concentration ofjth reaction, C is concentration vector of reactants, fy

is flux ofjth reaction, ^Gj' and AG"0 are the vectors ofjth reaction further transformed
Gibb’s free energy under steady-state and equilibrium condition, respectively. Table V.3
lists the enzyme activities, the Gibbs free energy changes, and the metabolic fluxes for

the glycolysis in astrocytes and neurons under KD conditions.

Table V.11. Enzyme activities, Gibbs free energy changes, and metabolic fluxes for in
the cytosol of astrocytes and neurons under KD conditions.

Ketogenic Diet

Enzyme Activity

AG

Reaction

Astrocyte Neuron

Astrocyte Neuron Astrocyte Neuron

Glc to G6P

1.49E-02

4.90E-01

-17.708

-30.63

0.453

0.047

G6P to F6P

4.95E-02

4.01E-03

-17.552

2.563

0.453

0.047

F6P to FDP

1.36E-02

2.79E-01

-7.23

-35.27

0.453

0.047
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Flux

FDP to GAP+DHAP

4.18E-02

8.98E-04 -15.477

28.418

0.453

0.047

DHAP to GAP

5.90E-02

3.12E-03

-11.129

-2.308

0.453

0.047

GAP to 13PG

2.28E-02

3.98E-03

-2.925

5.611

0.906

0.094

13PG to 3PG

4.88E+31 3.36E+35 -13.806

-4.234

0.906

0.188

3PG to 2PG

9.80E-02

1.10E-02 -13.901

5.166

0.906

0.376

2PG to PEP

1.57E-01

7.48E-03

126.521 0.906

0.752

PEP to PYR

2.29E+34 1.51E+35 -16.317

-22.546 0.906

1.504

LAC to PYR

-8.03E-03 5.70E-03

-3.852

PYR to AcCoA

1.60E-02

-2.903

-10.626

5.87E-02 -11.796

-0.79

-444.728 0.116

0.79
1.044

The results for the steady state, i.e. species concentrations under different diets are
listed in table V.4.

Table V.12. Steady state species concentration of different diets in neurons (N) and
astrocytes (A).
ND
Glc

A
8.98E+00

N
8.82E+00

5% KD
Glc

A
9.01E+00

N
6.69E+00

10% KD
Glc

A
5.04E+00

N
8.02E+00

15% KD
Glc

A
9.54E+00

N
1.67E+00

G6P
F6P

8.72E+00
3.88E+00

5.92E+00
1.47E-01

G6P
F6P

4.67E+00
6.11E+00

4.34E+00
6.32E+00

G6P
F6P

9.54E+00
9.89E+00

8.06E+00
7.48E+00

G6P
F6P

1.19E+00
1.51E+00

7.78E+00
9.22E+00

FDP
GAP

6.40E+00
2.36E+00

9.29E-01
8.10E+00

FDP
GAP

4.80E+00
5.57E+00

5.37E+00
7.47E+00

FDP
GAP

4.26E+00
3.67E+00

6.78E+00
5.97E+00

FDP
GAP

7.31E+00
4.18E-01

4.84E-01
9.80E+00

DHAP
13PG

9.39E+00
6.45E+00

6.84E+00
4.22E+00

DHAP
13PG

4.29E-01
8.42E+00

8.17E-01
2.12E+00

DHAP
13PG

2.32E+00
4.90E+00

5.42E+00
6.27E+00

DHAP
13PG

6.97E-01
5.80E+00

4.61E+00
3.35E+00

3PG

1.78E+00

7.47E+00

3PG

6.23E+00

1.68E+00

3PG

2.42E+00

9.85E-01

3PG

8.27E+00

1.69E+00

2PG
PEP

8.35E-01
6.02E+00

4.05E-01
9.97E+00

2PG
PEP

1.76E+00
2.87E-01

8.60E+00
6.05E+00

2PG
PEP

4.32E+00
4.90E+00

1.50E+00
6.62E+00

2PG
PEP

9.97E+00
7.53E-02

7.90E+00
8.07E+00

PYR
LAC

2.26E-01
4.99E+00

2.26E-01
6.38E-01

PYR
LAC

2.27E-01
5.00E+00

7.20E+00
6.60E+00

PYR
LAC

2.26E-01
4.99E+00

3.39E+00
7.44E+00

PYR
LAC

2.26E-01
5.01E+00

4.32E+00
7.93E+00

ATP
ADP

1.42E+00
1.22E+00

2.78E+00
1.17E-01

ATP
ADP

5.40E+00
6.88E+00

1.02E-02
7.50E-02

ATP
ADP

3.23E+00
5.76E+00

3.62E-01
2.86E-02

ATP
ADP

8.30E+00
9.31E+00

8.47E+00
1.61E-01

NAD+
NADH

4.37E+00
9.46E+00

4.31E+00
7.17E+00

NAD+
NADH

5.81E+00
9.84E+00

3.65E+00
9.58E+00

NAD+
NADH

2.66E+00
7.70E+00

3.93E+00
6.34E+00

NAD+
NADH

8.68E+00
8.31E+00

4.77E+00
7.39E+00

Pi
AcCoA m

4.76E+00
9.31E+00

8.04E+00
Pi
8.10E-01 AcCoA m

4.68E+00
7.16E+00

2.02E+00
Pi
8.34E+00 AcCoA m

3.76E+00
7.12E+00

9.14E+00
Pi
8.52E+00 AcCoA m

1.14E+00
3.92E+00

6.96E+00
3.45E+00

Next, we will find the BHB concentrations as well as transport and metabolic
parameters for normal and ketogenic diets as follows: (1) BHB will transport from blood
to extra-cellular space (EC). The diffusive transport mechanism flux can be formalized as
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liniHmoo^c = D(CBHBBi00d

—

^CBHB_EC)

(26)

Where D is diffusion coefficient or mass transport constant, a is a unit conversion factor.
Brain tissue weight

1.4 kg

n

,-kgx

O =--------------------------=------= 0.286 (—)
Whole body blood volume
4.9L
L

(27)

The brain tissue weight and blood volume can be readily found in reference materials
(Stevanovic, 2019).

We know the BHB flux from blood to tissue, the BHB concentrations in blood, in
the EC, and in the mitochondria from literature (Puchowicz et al., 2005), so we can easily
calculate the mass transport constant (or diffusion coefficient) D.

The facilitated transport mechanism use following equation
CbHB,EC
CBHB,Cytosol )
JBHBEc^Cyt = ^max (—
Mt+CBHB,EC Mt+CBHB,Cytosol

(28)

Where Tmax is rate constant and Mt is affinity of MCT. Here we can assume that lactate
and BHB transport is facilitated by the same transporters, MCT, therefore the facilitated

transport parameters for BHB are the same as those corresponding to lactate facilitated
transport. With the BHB concentration in the EC space, we can calculate the BHB

concentration in cytosol.
In the metabolic model one can use the following equation
JBHB^AcCoAMit0

= $1- $2

(29)

V1CBHBm

c . CBHB_rn . CAcCoA_m
1+ K1
+
K2

(30)

c CAcCoA_rn

02 =----- 2-^2--------- . CBHB_rn . CAcCoA_m
1+ Ki
+
K2

73

(31)

Where V1~2 are rate constants, which are unknown, and K1~2 are affinities, which are

known.
These four parameters are all connected with the equilibrium constant via the
Haldane relationship, i.e.
^qeq _ £2! _ fÆ

C™

(32)

V,Kt

Similarly has it was described in Chapter 3, it is simple to demonstrate that only
one of the reaction constants will remain unknown. This constant can be related to the

metabolic flux as shown below, i.e.
*2=1^

(33)

Then we replace V2 of Eq. (31), and the metabolic flux as shown below. i.e.
, V1K2 SacCoA m

,, CBHB m

JBHB^AcCoAMito

=------ L_£1---------------- ■
1 .

CBHB_m . CAcCoA_m
Kl
K2

■■

'.------

(34)

. CBHB_m . CAcCoA_m
K1
K2

( CBHBm CAcCoAm \

JBHB^AcCoAMito

=

V1 1

—----- ^1— 1

\ ! 1
\

CBHBm
^1

(35)

! CAcCoAm /

^2

/

The BHB relative concentrations and parameters of transport mechanism and metabolism
in normal and ketogenic diets are listed in table V.5.

Table V.13. BHB relative concentrations and parameters of transport mechanism and
metabolism in normal and ketogenic diets.
A. Diffusive mass transport parameters for ketone bodies (blood to extra-cellular space).
BHB Diffusive Transport
Mechanism

Diet

ND
KD

From
C_BHB_Blood
(mM)

0.20
2.30

To
Flux
C_BHB_EC
(mmole/kg) J (mM/min)
0.04
0.18
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1.00E-03
0.24

Diffusion coe.(1/min)
D (1/min)

Blood-EC unit
conversion factor
^ (kg/L)

0.01
0.11

0.286
0.286

B. Facilitated transport parameters for ketone bodies (extra-cellular space to cytosol).
BHB Facilitated Transport
Mechanism

EC->Cytosol

C_BHB_Cyto_N
Tmax (mM/min) M (mM)
(mmole/kg)
3.60
2.50
3.93E-02
3.60
2.50
1.24E-03

Diet
ND
KD

C. Facilitated transport parameters for ketone bodies (cytosol to mitochondria).
BHB Facilitated Transport
Mechanism

Cytosol->Mito

C_BHB_Mito_ Tmax
(mM/min)
M (mM)
N (mmole/kg)
0.10
3.60
0.25
3.60

Diet
ND
KD

2.50
2.50

D. Metabolic parameters and AG for the reactions involving BHB, AcCoA, and
Glutamate in neurons.
Keto Metabolism

Source
BHB
AcCoA

Product
AcCoA
Glutamate

,•
KA (mM) KB (mM)
VA N (mM/min) VB N (mM/min) AG"0reaction
0.006
0.006
1.0235
1.0453
76.80
0.45
1.1
0.042188
0.0074477
752.29

The concentration of glutamate in mitochondria is adapted from the literature (Patel et al.,
2004).
E. Glutamate concentration in neuronal cytosol.
Species
Glutamate

C_Cyto_N
(mmole/kg)
11.8
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CHAPTER VI

LACTATE DYNAMICS DURING NEURONAL ACTIVATION: KETOTIC
CONDITIONS

The robustness of the formulated model was demonstrated in Chapter IV. Indeed,
the model showed that it could reliably predict metabolic qualitative trends in brain tissue

under conditions of activation or neuronal stimulation. In this section, the model is
extended to examine metabolic responses under ketotic conditions by investigating the
effect of ketone bodies on lactate dynamics. However, recognizing that the actual

contribution of ketone bodies to brain metabolism is still unknown, an analysis of lactate
dynamics under different conditions of ketosis will be examined.

The analyses performed below were conducted assuming that at baseline
conditions the ketone metabolism contributes to ~20% of the total brain metabolism for

ketogenic diet conditions. In order to facilitate comparisons, the concentrations of lactate

under ketotic conditions were normalized against lactate values corresponding to standard
diet (or control) conditions (Fig. VI.1).
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Figure VI.14. Lactate concentration dynamics following a single stimulus of 5-s and
recovering peaks at 2 min to 170% of the baseline (pre-stimulus levels at t = 0: min).
Dynamic response shown as lactate normalized concentration for standard (control, solid
blue line) and ketogenic (red dashed line) conditions. Concentration levels for ketotic
conditions were normalized with respect to baseline conditions corresponding to the
control diet (concentration stimulus/ concentration baseline-control diet).
The changes in the dynamic behavior of lactate levels in the cytosol of the neuron

under the influence of ketogenic diet with a 5-sec sustained stimulus exhibited a ~2%
decrease (relative to the baseline condition). Similarly to what was observed in the
standard diet conditions, lactate concentration peaks after approximately 2 mins. As

compared to standard diet conditions, the lactate levels were ~35% lower under ketotic
conditions. This inhibitory effect on lactate accumulation could be explained by the

additional flux of ketone bodies in the TCA cycle following a decrease in neuronal
activity.
The dynamics of the fluxes associated with lactate mass balances under ketogenic
diet demonstrated that the dynamics of these fluxes are similar to those observed for

standard conditions (Fig. VI.2).
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Figure VI.15. Flux dynamics of cytosolic lactate in standard and ketotic conditions.
Following a single stimulus of 5-s:
(A) ^1: Net flux of lactate entering the cytosol from extra-cellular space; (B) ^2: Lactate
oxidation flux in the reaction of lactate to pyruvate in the cytosol; (C) ^3: Net flux in the
transport of pyruvate in the cytosol to the mitochondria increases; and (D) ^4: Net flux
from citrate to a-KG. The flux values were normalized with respect to normal (control)
diet conditions as described in Fig. VI.1.
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All flux values are normalized with respect to those of the standard diet (or

control) conditions. The dynamics of some of the major TCA cycle fluxes were
examined. These fluxes showed the same levels at steady state, but the amplitudes of the
deviations from baseline conditions during stimuli were smaller than those observed for
standard diet conditions (Fig. VI.2 & 3).

GABAto SSA
Normal diet
Ketotic diet

200

400

600

800

1000

Time (s)

Time (s)

Figure VI.16. Flux dynamics associated with the glutamate-glutamine cycle, the GABA
shunt, and malate shuttle in standard and ketotic conditions.
Net fluxes change following a single stimulus of 5-s. (A) ^5: Net flux from a-KG to
succinyl-CoA; (B) ^6: Net flux from GABA to succinic semialdehyde; (C) ^7: Net flux
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from acetyl CoA to citrate in the TCA cycle; and (D) ^8: Net flux from malate to
oxaloacetate in the mitochondria.

The dynamics of lactate levels under ketosis during a periodic stimulation of 5 sec
followed by a rest periods of of 2 min, were also investigated. The simulations showed

similar dynamic profiles for both diet conditions; the magnitudes of the lactate levels
deviations, however, were smaller under ketotic conditions as compared to those

observed during neuronal activation under standard diet (Fig.VI.4).

Figure VI.17. Dynamic response in lactate concentration (normalized) during 10
repeated stimuli: 5-s stimulus followed by a 2 min rest interval.
Dynamic response shown as lactate normalized concentration for standard (control, solid
blue line) and ketogenic (red dashed line) conditions. Concentration levels for ketotic
conditions were normalized with respect to baseline conditions corresponding to the
control diet (concentration stimulus/ concentration baseline-control diet).

These findings are consistent with the higher tissue lactate levels observed under
standard diet conditions, suggesting that ketone bodies contributions to the regulation of
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the TCA cycle activity in the mitochondria, and lower glucose level in blood, result in a
decrease of extra-cellular lactate levels.
In normal (or control) diet, the steady state and dynamic total CMRs will provided

by a flux of glucose. In ketotic diet, the supply of glucose is not enough to meet the

substrate (total CMR) demand, this deficiency is completed by the pHB flux contribution
to the total CMR. In our CAPK model, it has been considered that, for conditions of

ketone bodies saturation, the ketotic diet can deliver a maximum pHB flux of 0.24
mM/min. A pHB flux (2 carbons per molecule) of 0.24 mM/min will be equivalent to

0.08 mM/min of glucose (6 carbons per molecule) flux, then the pHB contribution to the
total CMR will be ~14% (0.08/0.58). To examine the sensitivity of the model to changes

in the flux of ketone bodies, we decreased the pHB flux to 0.16 and 0.08 mM/min, i.e.
~9% and ~5% of the total CMR, respectively. These conditions are tabulated below in

Table VI.1.
Table VI.14. Conditions (flux of pHB/ Total CMR) used to examine the dynamics in the
extra-cellular lactate concentration for a single electrical stimulus._____ ______________
Cerebral glucose metabolic rate
p HB flux (mM/min) p HB fux*(2C/6C)
(mM/min)
p HB/CMR %
0
0
0.58
0%
0.08
0.027
0.553
5%
0.16
0.053
0.527
9%
0.24
0.080
0.500
14%

The predicted extra-cellular lactate concentration dynamics for a single electrical
stimulus is shown in Fig. VI.5.
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Figure VI.18. Dynamic response shown as (normalized) lactate concentration for
different levels of ketosis.
Diets indicated as varying percentages of ketone bodies entering the TCA cycle following
a 5-s stimulus show lactate profiles in ketotic conditions to be same as the standard
conditions irrespective of contribution from ketone bodies.
Although, we found that the lactate levels decrease under ketotic conditions (Fig.
VI.1 and 5), the major finding from these sensitivity studies was that the levels of lactate
for varying ketone body contributions to metabolism (5-14%) showed to directly
correlate with the contribution of ketone bodies flux to the total CMR.
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CHAPTER VII

DISCUSSIONS AND CONCLUSIONS
A phenomenological metabolic model for mammalian brain tissue was formulated

in this Dissertation. The model was validated via experimental data (Hu & Wilson, 1997)
on the dynamics of lactate in extra-cellular space under conditions of the neuronal
activation. The model was validated using reported data for standard diet conditions.
One of the main goals of this study was to examine the carbon flux balance shift

stemming from the metabolism of ketone bodies in neurons. This shift was hypothesized
to result in a proportional decrease in the glycolytic activity in astrocytes. Model

predictions for lactate under standard diet conditions allowed to examine changes in
metabolic fluxes both in the mitochondria (TCA) and cytosol (ANLS). The model

predicted an increase in the flux of lactate conversion to pyruvate under activated
conditions, as well as an increase in the lactate concentration levels following a periodic

stimulation pattern.
Dienel’s research on a lactate release model, stated that that astrocyte-produced
lactate will not only be transported to neurons, but will also be released to blood (Dienel,

2013). Since cerebral metabolic rates (CMR) of glucose consumption can be measured by
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following the CO2 producing rate, this release results in an underestimation of the
CMR of glucose consumption, Indeed, if a fraction of the lactate is released to blood

instead of being oxidized, CMR will be underestimated by the CO2 release rates when

compared to glucose consumption. In the model formulated in this dissertation the flux

rate of the astrocyte-neuron lactate shuttle (ANLS) estimated at steady state suggests that
the net lactate release flux to blood is null at steady state.
In the TCA cycle (mitochondria), the model predicted an increased flux from

acetyl-CoA to citrate and from citrate to aKG, supporting the bio-chemical mechanism
known for the TCA cycle: changes in citrate levels are known to be metabolic regulators

of glycolysis and ATP production. Thus, for instance, examination of these fluxes during
neuronal activation revealed a negative trend (deceleration) in the flux of citrate to aKG
during the recovery from the stimulus, suggesting a decrease in citrate levels. These

results also are consistent with an increase in the aKG to succinyl-CoA flux (during
stimulus); which accounts for the flux partition from acetyl-CoA towards glutamine
(through OAA), which has been reported to increase during ketogenic diet conditions

(Melo et al., 2006). The increase in the net flux of malate to oxaloacetate reflects the
decreased activity of the malate aspartate shuttle as a result of the stimulus.

Under the state of ketosis, induced by different ketogenic diet levels, model
predictions showed a similar increase in the lactate levels in Fig. VII.1 (~ 70%) following

a stimulus than those observed under standard diet conditions.
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Figure VII.19. Dynamic response shown as (normalized) lactate concentration for
different levels of ketosis.
Diets indicated as varying percentages of ketone bodies entering the TCA cycle following
a 5-s stimulus show lactate profiles in ketotic conditions to be same as the standard
conditions irrespective of contribution from ketone bodies.

This suggests that there is a weak coupling between the ketone bodies metabolism

and the glucose metabolism, possibly at the level of glycolysis. Thus, ketone bodies
metabolism can be hypothesized to regulate glycolysis (described by the ANLS theory).

These analyses further extend the following observations:

(1) The dynamic response of lactate concentration levels to changes in ^HB

concentrations for a single stimulus showed similar (~70%) differences with
those observed for standard diet conditions. However, with cyclic stimuli,
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lactate concentration shows a cumulative effect, and the differences of lactate

concentration levels between ketotic and standard diet conditions became

markedly different. This suggests that stimulus induced neuronal activity
(with the corresponding changes in CMR) may be weakly coupled to ketone-

body metabolism as well as to the ANLS.
(2) The net flux of pyruvate from cytosol to mitochondria was found to decrease
during ketotic conditions as compared to the values observed for standard diet

conditions. This is in correspondence with the assumption that a fraction of
the TCA cycle flux (assumed to remain constant at steady-state for both
control and ketotic conditions) is sustained by ketone bodies.

(3) Ketotic conditions affect the dynamics of the fluxes associated with the

activation of the TCA cycle (acetyl-CoA to citrate) and the GABA
shunt/glutamate-glutamine cycle when compared to the dynamics observed
for standard diet conditions. However, this study only used the dynamics of
extra-cellular lactate levels to validate the metabolic model, and used changes

in metabolic fluxes to express distinct outputs in control diet conditions (this
study did not validate the extra-cellular lactate levels in ketotic diet). These

fluxes reflect the possible change of the species levels under different diets.

Since metabolic fluxes depend on the species concentration, as well as kinetic
and transport parameters, our modeling dynamic flux curve is similar to the

experimental data for the same parameters.
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Based on these findings, one could speculate metabolic pathways associated with

ketone bodies can be coupled with glycolytic activity (both in astrocytes and neurons);

which is independent of the activity of the TCA cycle. While the contribution of the
ketone bodies to sustain TCA activity has been widely recognized, the actual contribution

of ketone bodies to the TCA cycle is unknown, particularly during activated conditions.
However, even with a potential ~14% fuel substitution provided by ketone bodies; the
lactate response did not appear to vary significantly qualitatively (Figs. VII.1 and 2).

Figure VII.20. Lactate concentration dynamics following a single stimulus of 5-s and
recovering peaks at 2 min to 170% of the baseline (pre-stimulus levels at t = 0: min).
Dynamic response shown as lactate normalized concentration for standard (control, solid
blue line) and ketogenic (red dashed line) conditions. Concentration levels for ketotic
conditions were normalized with respect to baseline conditions corresponding to the
control diet (concentration stimulus/ concentration baseline-control diet).

We recognize that by incorporating several components (pathways) highlighted in
the literature (Shulman et al., 2004) the model presented here is a significant outgrowth to

most available metabolic models. However, some of the features seem to suggest that the
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model presented may be missing a potential coupling between the metabolism of ketone

bodies and the glutamate-glutamine cycle (Vcycle).
Aiming to shed light on the intricate mechanisms associated with the metabolism

of ketone bodies in brain tissue, this is one the key issues that requires further
investigation. The model needs to be expanded to enable examining potential coupling

mechanisms between Vcycle , glycolysis (neuronal and astrocytic), and ketone body

metabolism. At present, one of the main difficulties hindering these developments if the
lack of suitable experimental data to compare the output under different diet conditions.

Therefore, in the next Chapter suggested experiments are designed to produce
results to validate and extend this model.

88

CHAPTER VIII
FURTHER RESEARCH

Although the model formulated in this dissertation revealed a number of
metabolic phenomena associated with ketone bodies in mammalian brain metabolism,

there are a number of unanswered questions.

Indeed, one of the driving motivations for this study was elucidating the effect of
ketogenic diets (KD) on metabolic process, which may affect the development and

progress of Parkinson’s disease. It was shown how the increases in lipid and ketone
bodies (KB), accompanied by a decrease in the glucose intake result in a substitution of
glucose as the main energy source for brain. This is a natural consequence of ketogenic

diets, since the substrate intake during KD cannot provide the brain with sufficient energy
from glucose; therefore, requiring of a complement of energy derived from lipids and

KB.

Further studies, will require incorporating into the model the connection between

glucose and PD progression by connecting glycolytic fluxes with the loss of functionality

of complex I. The stages formulating this connection are illustrated in the flowchart
shown in Figure VIII.1 below.
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Figure VIII.21. From glucose concentration to PD progression rate.
This aim will require formulating a model capable of reproducing concentration

levels of glucose in the extra-cellular space of neurons and validation via experiments

including glycolytic flux rate measurements. Fig. VIII.2 below shows the relationship
between glucose concentration and the normalized hexokinase reaction rate. Since

hexokinase catalyzes the first step in the glycolysis, these data can be used to correlate
glycolytic flux with glucose concentration levels.

The normal blood glucose concentration varies between 3-5.5 mM, this
concentration range has been identified in Fig. VIII.2, which shows that the glycolytic flux

is at its highest level for standard conditions.
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Figure VIII.22. Relationship between glucose and the first step reaction rate of glycolysis
(Palmer & Palmer, 2014).
Fig. VIII.3 shows the relationship between the glucose concentration of adipocytes
(storage fat cell) and free radical intensity. These measurements were carried out in vitro

for adipocytes suspended in phosphate-buffered saline (PBS) solution, which replicates an
environment similar to that of the extra-cellular space in brain tissue.
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Figure VIII.23. Relationship between glucose concentration and free radical intensity
(Talior et al., 2003).
DCF (2’,7’ -dichlorofluorescin) is the free radicals level probe. In the reaction of 2 DCHF
+ H2O2 ^ 2 DCF + 2 H2O, where DCHF is 2’,7’ -dichlorodihydrofluorescin. The increase
of free radicals (H2O2) concentration will increase the DCF concentration.

Literature data suggests that there is a direct correlation between the inhibition of
complex I and the concentration of free radicals in the cells. Free radicals will block the

respiratory chain of complex I, and result to the formation of ubisemiquinone increasing.

The increasing of ubisemiquinone, the major electron donor of superoxide production, will

induce higher superoxide level. Superoxide is also classified as free radicals. Therefore,
more respiratory chain of complex I will be blocked, which will induce the loss of

functionality for complex I . Figures VIII.4 (A) and (B) (Li et al., 2003) show two neuronal

behavior effects induced by rotenone, a well-known complex I inhibitor.
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Figure VIII.24. (A) Relationship between complex I inhibitor, rotenone, and free
radicals, peroxide, concentration. (B) Relationship between percentage of cell respiration
and the concentration of rotenone (Li et al., 2003).
Fig. VIII.4 clearly suggests a relationship between the concentration of free radicals

and cell respiration. If we can associate cell respiration with cell functionality, data like
this can be utilized to formulate a relationship between glycolytic flux and loss of cell

functionality. These observations suggest the need to include the dynamics of the free-

radicals concentration in an expanded formulation of the metabolic model.

Since one of the aims of the the metabolic model is to elucidate the connection between
glycolytic fluxes and progression of neurological disorders, the relationship between the

percentage of neurons that lose functionality and the percentage of neurons whose loss of
functionality can be associated with PD needs to be drawn next.

A preliminary connection between these types of neurons can be drawn from
glucose utilization data, such as that presented in Table VIII.1 below
Table VIII.1. Glucose utilization rates in brain tissue (Dermon et al., 1990)
Glucose Utilization Rate
(gmol/1 OOmg/min)

Whole Brain

5001 + 20

Substantia Nigra

104 + 7

SN/Brain

2.08 + 0.14%
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A more direct connection can be drawn from a relationship between the substantia
nigra cells that are losing functionality and the changes in the PD progression rate.

Experimental data relevant for this connection is presented below.

Figure VIII.25. Substantia nigra losing functionality increased with time (Burciu et al.,
2017).
Indeed, Burciu’s study (Burciu et al., 2017) clearly suggests a relationship between
the percent of substantia nigra that has lost its functionality and the progression rate of PD.
In summary, by correlating experimental data as the one presented above, a model

for the route between the extent at which glucose sustains brain energy demands (i.e., its
metabolism) and its connection to the progression rate PD can be formulated and added to
the metabolic model.
Transporters play an essential role in the role of the different substrates in the

energy metabolism in brain tissue. Transporters regulating the availability of glucose,
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lactate, and ketone bodies to cells are essential in understanding metabolic changes under
different diets. One important mechanism affecting facilitated transport fluxes is the
transporter self-regulation. For instance, there is evidence that MCT self-regulation might

express different activity under different pH, lactate level, and hypoxia conditions
(Caruso et al., 2017). These interrelations might prove essential to better correlate diets

and tissue substrate levels with metabolic responses in brain tissue and should be

incorporated into a more detailed model.
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APPENDIX A

REACTIONS OF GLYCOLYSIS

Hexokinase(HK)

_______ Glucose + ATP <
Glucose 6 phosphate(G6P)

> Glucose 6 phosphate(G6P) + ADP_______

Phosphoglucose isomerase (PGI)

> Fructose 6 phosphate (F6P)_____

___________________<

Fructose 6 phosphate (F6P) + ATP
Phosphofructokinase (PFK1)

> Fructose 1,6 bisphosphate (F1,6BP) + ADP
Fructose 1,6 bisphosphate (F1,6BP)

_____________ <

Fructose-bisphosphate aldolase (ALDO')

<----------------------------------------- > Glyceraldehyde 3 phosphate (GADP)
________________________________ +Dihydroxyacetone phosphate (DHAP)
Dihydroxyacetone phosphate (DHAP)
Triosephosphate isomerase (TPI)

' ~ >> Glyceraldehyde 3 phosphate (GADP)

______________ <

Glyceraldehyde 3 phosphate (GADP) + NAD+
Glyceraldehyde phosphate dehydrogenase (GAPDH)

<----------------------------------------------------- > 1,3 Bisphosphoglycerate (1,3BPG)
____________________________________________ +NADH___________________
Phosphoglycerate kinase (PGK)

1,3 — Bisphosphoglycerate (1,3BPG) + ADP <--------------------------------> 3
________________ — Phosphoglycerate (3PG) + ATP_________________________
Phosphoglycerate mutase (PGM)

3 — Phosphoglycerate (3PG) <--------------------------------- > 2
______________________ — Phosphoglycerate (2PG)_________________________
Enolase (ENO)

2 — Phosphoglycerate (2PG) <-----

> Phosphoenolpyruvate (PEP) + H20

'

Pyruvate kinase (PK)

Phosphoenolpyruvate (PEP) + ADP < '

107

> Pyruvate (Pyr) + ATP

APPENDIX B

REACTIONS OF TCA CYCLE

Pyruvate dehydrogenase

Pyruvate + CoA — SH + NAD+ <------------------------- >Acetyl — CoA + CO2
______________ +NADH_______________________________________________
Citrate synthase

Oxaloacetate + Acetyl CoA + H2O <—

> Citrate + CoA—SH

Aconitase

________________ Citrate <

> cis — Aconitate + H2O________________
Aconitase

_______________ cis — Aconitate + H2O <

> Isocitrate________________

Isocitrate dehydrogenase

> a — Ketoglutarate + CO2 + NADH

Isocitrate + NAD+ <

aKetoglutarate dehydrogenase

a — Ketoglutarate + NAD+ + CoA—SH <-------------------------------- > Succinyl
____________ — CoA + NADH + CO2____________________________________
Succinyl-CoA synthetase

Succinyl — CoA + GDP + Pi <------------------------- > Succinate + CoA — SH
_____________ + GTP_________________________________________________
Succinate dehydrogenase

Succinate + ubiquinone (Q) <-------------------------- > Fumarate
___________________+ ubiquinol (QH2)_________________________________
Fumarase

_________________ Fumarate + H2O <

> L — Malate_________________

Malate dehydrogenase
L — Malate + NAD+<----------------------- > Oxaloacetate + NADH
Transaminases
a — Ketoglutarate + NADH + NH4 + H+ <-------------- > Glutamate + NAD+
Glutamine synthetase
MCT
GlutamateAstrocyte ---------------------- > GlutamineAstrocyte —> GlutamineNeuron
Phosphate-activated glutaminase

> GlutamateNeuron
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APPENDIX C

CHEMICAL FORMULAS OF SPECIES OF GLYCOLYSIS, TCA CYCLE AND
SOME RELATIVE REACTIONS
Species
Glucose
Glucose 6 phosphate
Fructose 6 phosphate
Fructose 1,6 bisphosphate
Dihydroxyacetone phosphate
Glyceraldehyde 3 phosphate
1,3-Bisphosphoglycerate
3 -Phosphoglycerate
2-Phosphoglycerate
Phosphoenolpyruvate
Pyruvate
Lactate
Acetyl-CoA

Abbreviation
Glc
G6P
F6P
F1,6BP
DHAP
GADP
1,3BPG
3PG
2PG
PEP
Pyr
Lac
AcCoA

Oxaloacetate
Citrate
Isocitrate
cis-Aconitate
a -Ketoglutarate
Succinyl-CoA

OAA
Cit
Iso-cit
Cis-Aco
a-KG
Suc-CoA

Succinate
Fumarate
Malate
Glutamate
Glutamine

Suc
Fum
Mal
Glu
Gln
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Chemical Formulas
C6H12O6
C6H13O9P
C6H13O9P
C6H14O12P2
C3H7O6P
C3H7O6P
C3H8O10P2
C3H7O7P
C3H7O7P
C3H5O6P
C3H4O3
C3H6O3
C2H3O-CoA
C23H38N7O17P3S
C4H4O5
CeHsOï
C6H8O7
C6H6O6
C5H6O5
C4H5O3S-CoA
C25H40N7O19P3S
C4H6O4
C4H4O4
C4H6O5
C5H9NO4
C5H10N2O3

APPENDIX D

EQUATIONS OF METABOLISM
Species
Glucose

Equation
dC-t r

=

dt
T

...
01 02 03

+ 04

T1(C1.xc)

_

01

+

M1
0

.

C1,xc

+ C1,c

T2(C1,c)

-

02
M1

v

+ C1,xc + C1,c

Cic

ps%+

i

A
03 —
e C22,cc 1 + PS+/ +
11 +I Cl
1,c I
M
17 + 17
“1
“2
r.
1/
2,c
r ps-/ _ i
M
^2 A
/M
i7i
—
2
04 —
[1 + PS-/M-]
c
1 1 Cie
1,c 1 C22,c
A1
À2
M

dC2 r
...
.
= 03 04 05 + 06
dt

G6P

17

Notation
C:Concentration
1: Glucose
c: Cytosol
0: Flux
xc: Extra
cellular space
B: G6P
2: G6P
PS+ =
Catp/Cadp
PS- = 1/PS+

corresponding
controller
coefficients

3: F6P

C? e
2,c

M

^ A

i7i

3

05 —
=

l + jp + jp
A3
a4

M
i7i —
06 =

1/

Co r
3,c

^ A

4

1 +n2£ + n32
A3

F6P
.

5
07

a4

dCo r
-— — 05 - 06 - 07 + 08
dt
Co r
i
■
'7.

—

5

_l C3,c I C4,c 1+PSX+
M
1+ A + A

1
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4: F1,6BP

Parameter
Ti: Transport
mechanism rate
constant of
glucose from
blood to cytosol
T2: Transport
mechanism rate
constant of
glucose from
extra-cellular
space to blood
Mi : Affinity of
transporter
GLUT
Vi: Metabolism
rate constant of
glucose to G6P
V2: Metabolism
rate constant of
G6P to glucose
Ki: Affinity of
glucose of HK
K2: Affinity of
G6P of HK
V3: Metabolism
rate constant of
G6P to F6P
V4: Metabolism
rate constant of
F6P to G6P
K3: Affinity of
G6P of PGI
K4: Affinity of
F6P of PGI

0-

V‘C
^

08 —

1 -j- ^3,c _1_ £i£

K

1+ Ks +

F1,6BP

PS-/
/u1 + PS7u-l

aC4c

— 07

at

09 —

09 + 010 + 011

08

5: GAP
6: DHAP

1 -j- CFc , ^5,c , Q,c

1 + zz + zz + zz
K7

T7

K

U8

-

01O —

K9

K8

C5
c
5,c
IZ8
K

1 -j- C4,c । C5,c , C6,c
1+
+
+
K7
K8
K9
r
C -66

^9 K9

m
M

9

—

011 =

n
n
n
1 -j- C4,c । C5,c , C6,c
1 + ZZ + zz + zz
K7
K8
K9

GAP

dC

— 09

at

012 + 013

0io

01 4

+ 015
T7

^10

-

K

012 —

_

1+

IZ

K1o

Ce
^^¿^
K10

_

C.r
__6,c

+ Kn

r
1/ -6c
^11 IZ
K11

-

k

C55c
,c

7: 1,3PG
RS+= Cnadh/
Cnad
RS' = 1/RS+
v:
corresponding
controller
coefficients

C5c
6,c
1+75^ +, C
K10 Kn
C5c
T7
PS+/
^12 iz5,c
/v+

^13

K

K12

-

014 —

.

•1

1

Ce
C7r
5,c
7 ,c
+ K12 + K13

b+8s7v+.

C7c

K
015 —

T7
^13 iz7,c
K13

^
_
[1 + flS-/v-.
. C5c C7c
1 +t5c + t7c
K12

DHAP

at

1,3PG

K13

dC

— 09

0n

013 + 012

— 014

015

016 + 017

dC

.

at
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8: 3PG

C7c
TZ
/,c
^14 V

K

PS-/

/uK14
Gc Qc 1 + ""A-]

-

016
—
16

8>c
Kis

1 1
',c 1
1 + K14 +

m

017

TZ £§■£
^15 Kis

_
—

1 + P5+/u+
C7r
Gr
' ,c 1
8,c
1 + K14 + K151

1

1

cZ C

3PG

PS%+

= 0 16

at

017

9: 2PG

018 + 019

v C8,c
v16 K
K16

K 018 —

1 +£8i£_|_£91£

1 + K16 + K17

i?K-

0 019 —

2PG

„

„

G8,c . G9,c
1 + K16 + K17

1

I

10: PEP

dC

= 018

at

0

,,“Kc

-

020 —

1

1

e
e
_l_ G9,c I G10,c
+ K18 + K19
T/

K

02O + 021

019

^‘*10,c

^19 V
K19
„
„

-

021 —

I G9,c । G10,c
1 + K18+ K19

1

PEP

i^ — 020 - 021
at
TZ G10,c
^20 V
K20

022 —
K

g

, G10,c

1 + K20
y
K

023 —

^21

- 022

+ 023

11: Pyruvate

PS-/u
/ _
[1+ PS-/u- ]

, G11,c

1 K21

G11c
V
K21

[ PS+/u+

^
^
1 , G10,c , G11,c .1+PS%+
1 + K20 1 k

21

Pyruvate

dC

at

— 022

023

024 + 025

+ 027
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026

12: AcCoA
13: Lactate
m:

^L1'

M
024 =

~2 _

_

1 _i_ T11.c I

Mitochondria

^22
V23>
RSm/
/v
“23
[1 + RSm/vCii,c
11r । T12,m
2 rn
^22
^23

^
025 =
•4

^12,m
^23

RSm/
/v+
+ //v+_
[1 + RS
K^m

।

^T“

M

■

“24

-

026 _

, T11,c . T13,c
1 + ^24 1 ^25

R

4 + RS7v-l

t

.

027 =

Lactate

13c
1 C13,c

_

5 K25

„
„
, , T11,c , T13,c
1 + ^24 1 ^25

aT13.c

at
„

_

_ 026

_

027

RS+/
/V+
1+ R57V+]

. _

_

028 + 029

73(C13.<)

.

14: Lactate in
extra-cellular
space

028 _

+ T13.c + T14,rc
^4(T14.xc)
029 _ . .
„
„
M2 + T13.c + T14.xc
aT2m _ 024 - 025 - 030
at
^T2^
M2

_

AcCoA

030 _ ------------------30

15: Citrate
16: OAA

26-------------------

r
r
r
t । T12,m । u15,m . T16,m
1 + ZZ
1 ZZ
1 ZZ
a26
A27
^28

Citrate

_ 030 - 031

at

t

U27

17: Iso-citrate

T15,m

V
031_ ---------^9------31

Iso-citrate

a

c
c
. u15,m . ^17,m

^29
^30
^rr _ 031 - 032

032 _ ------------- 30-----------32

a

r
r
. u17,m . u18.m
^30 1 ^31
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18: a KG

T3
M2

a KG

^^^ = 032 - 033 - 034
at
TZ £18,m
RS+/
u29 /Z
ly+
M
Ä31
033
=
„c
_
33
c
1
u18,m
u19,m 1 + RS+/v+.
“31

ft 034
=
34

19: Suc-CoA
20: GABA

K33: affinity of
enzyme KG to
GABA
K34: affinity of
GABA to KG

“32

£18,m
/Z
“33
„c
_
c
, “18, m
“20,m
/<33 1 K34
U30

1

Suc-CoA

= 033 - 035

21: SSA

£19,m
035
35

GABA

=

„r

, “19,m
^35

1

a£20,m

at

ft

^35

= 034

„

r
“21,m
^36

1

036

■z £20,m
U32 /z

-

“36
C
C
a . °20,m . °21,m
^36 1 ^37
A— 0„.
037
at
^33^
RS+/
/v+
Ä
37
—
r
r
£ , °21,m . £22,m _1 + RS+/v+
^37
^38
^^22^ — 037 - 038
036 =

SSA

ft
037
37

Fumarate

22: Fumarate

23: MAL

1^34%*

ft

-

A38

C
C
a . °22,m . °23,m
^38
^39
^^^r— 038 039

038 =

MAL

TZ £23,m

ft
037 —

^35

/z

RS+/

/v+
Ä39
4 , £FT
23,m , £16,m 1 + RS+/v+
K39 1 ^40

OAA
at

— 039 - 030
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K40: affinity of
OAA to MAL

Glutamate

.

dC-iAr

.

-7= = 040 + 04 1 - 042
dt
^

-

040 =

c C18,m
V36 K
Ä41

[ ^^-/ve
c
[1 + RS-/v-\
a . C18,m . C24,c
1+^41 1 ^42
041 =-------- ^25 xc)

^3 + C24,c

24:Glutamate in
cytosol
25:Glutamate in
extra-cellular
space
26:Glutamine in
cytosol

+■ C25,xc
,m

13______

'4
c

. C24,m , C26,c
iz
Â43
^44

1+

Glucose

dC1 ■vr

dt

-

.

.

.

0i + 02 + 043

043 — D^C
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D: Diffusion
coefficient
Vc: Glucose
concentration
gradient
between blood
and extra
cellular space

APPENDIX E
PARAMETER NUMBER VALUES

(Lowry & Passonneau, 1964; Mulukutla et al., 2015)
Source

Product

VA(mM/min)

VB(mM/min)

Glucose

G6P
F6P

Calculated

Calculated

Calculated

F1,6BP
GAP

Calculated

G6P
F6P
F1,6BP
DHAP

GAP

KB(mM)

KA(mM)

Reference

0.1

0.47 Mulukutla, 2015

Calculated

0.96

0.123 Mulukutla, 2015

Calculated

0.032

0.3 Mulukutla, 2015

Calculated

Calculated

0.05

0.189 Mulukutla, 2015

GAP

Calculated

Calculated

0.43

0.162 Mulukutla, 2015
0.000671 Mulukutla, 2015

1,3PG
3PG

Calculated

Calculated

0.095

1,3PG
3PG

Calculated

Calculated

0.002

1.1 Mulukutla, 2015

2PG

Calculated

Calculated

0.168

0.0256 Mulukutla, 2015

2PG

PEP

Calculated

Calculated

0.046

0.11 Mulukutla, 2015

PEP

Pyruvate

Calculated

Calculated

0.225

Lactate

Pyruvate

Calculated

Calculated

0.87

4 Mulukutla, 2015
0.2 Lowry, 1964

Pyruvate

AcCoA

Calculated

Calculated

0.02

1.6 Mulukutla, 2015

AcCoA
OAA
Citrate
Isocitrate
alpha-KG
SucCoA
GABA
SSA
Fumarate
Malate
Glutamate

Citrate
Citrate
Isocitrate
alpha-KG
SucCoA
SSA
SSA
Fumarate
Malate
OAA
glutamine

Calculated

Calculated

0.02

NA Mulukutla, 2015

Calculated

Calculated

0.68

NA Mulukutla, 2015

Calculated

Calculated

0.0014

NA Mulukutla, 2015

Calculated

Calculated

0.183

NA Mulukutla, 2015

Calculated

Calculated

0.15

NA Mulukutla, 2015

Calculated

Calculated

0.055

NA Mulukutla, 2015

Calculated

Calculated

4.1

NA Mulukutla, 2015

Calculated

Calculated

0.467

NA Mulukutla, 2015

Calculated

Calculated

0.0447

NA Mulukutla, 2015

Calculated

Calculated

0.11

NA Mulukutla, 2015

Calculated

Calculated

0.45

NA Mulukutla, 2015

Transporter

T(mM/min)

GLUT
MCT

0.767
Calculated

M(mM)

Reference
1.5 Mulukutla, 2015

7.05 Mulukutla, 2015
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APPENDIX F

CONCENTRATIONS UNDER STEADY STATE CONDITIONS

Species

Blood and
interstitial
fluid
Conc.
[m M]

Cytosol
(Neuron/Glia)

Mitochondria
(Neuron/Glia)

Conc.
|H mol g-1ww]

Conc.
[^ mol g-1ww]

Reference

#

LAC

1.7#(STD)

0.79*/5.0# (STD)

1.1#(KTG)

0.49*/1.12*(KTG)

2004

-

*calculated

0.15#/0.226*

PYR

0.067#

(STD)

Puchowicz, et al.,

#

calculated

0.15#/0.226*

*Lowry et al., 1964

0.07#/0.06# (KTG)

CoA

-

-

0.687

Deutsch et al., 2002

ACoA

-

-

0.076

Deutsch et al., 2002

CIT

-

-

0.357

Harik et al., 1997

aKET

-

0.3375

0.9

assumed

SCoA

-

-

0.226

assumed

SUC

-

-

0.226

assumed

MAL

-

1.356

0.226

assumed

OAA

-

1.10

1.10

Mason et al., 1992

CO2

21.7

-

16.18

MIMS

ATP

-

2.36/2.36

2.36/2.36

Lowry et al., 1964

ADP

-

0.91/0.91

0.91/0.91

Lowry et al., 1964

NAD

-

4.37+/2.38*

4.37+/2.38*

NADH

-

4X10-4+/1*

4X10-4+/1*

O2

8.8

-

0.963

Zhou et al., 2005

Pi

-

-

0.24

assumed

H+

-

-

1.e-04

assumed

Lowry et al., 1964

+

*calculated

Lowry et al., 1964

+

*calculated
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BHB

0.2

0.1/0.11

Puchowicz et al.,

2.3*

0.25/0.02*

2005 (* Ketotic
conditions)

AcAc

0.12

-

0.12

Puchowicz et al.,
2004

PCr

-

4.2

-

Crumrine et al.,

1991
Cr

-

6.5

-

Crumrine et al.,

1991
Glutamate

-

49.2+

11.8

Patel et al., 2004

assumed

+

Glutamine

-

8.4

Patel et al., 2004

0.8925

2.38

Seisjo, 1978

-

-

0.226

-

-

2.1

-

Aspartate

Succinate
semialdehyde

Yaminobutyric
acid
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assumed

Patel et al., 2004

APPENDIX G
STEADY STATE FLUXES FOR CONTROL DIET CONDITIONS

Inter-compartment Transport Processes (Fluxes) and Substrate Interaction

1

Net Flux, pmol g-1ww min-1

Transport Process

1

Lactate Transport, C(cytosol, glia) >XC(extracellular space)

2

Lactate Transport, B(blood)^XC

Negligible

3

Lactate Transport, XC^C(neuron)

0.87

4

Pyruvate Transport, B^XC

Negligible

5

Pyruvate Transport, XC^C

Negligible

6

0.087

8

Neuronal glycolysis
Pyruvate Transport,
C (neuron)>M(mitochondria)
Pyruvate Transport, C(glia)>M

9

BHB Transport, B^XC

10

BHB Transport, XC^C

11

BHB Transport, C >M

N/A
N/A
N/A

12

AcAc Transport, B^XC

13

AcAc Transport, XC^C

14

AcAc Transport, C >M

N/A
N/A
N/A

15

Oxygen Transport, B^Tissue

3.48

16

Carbon dioxide Transport, Tissue^B

3.48

7

0.87

1.044
0.116

Reactions in the Neuron and Glia (Mitochondria/ Cytosol)

Overall Reaction

1

Net Flux ^mol g-1ww
min-1
Neuron
Glia

0.87

-0.87

1.044

0.116

19

Lactate
LAC + NAD+ ^ PYR + NADH + H+
oxidation/reducti on
Pyruvate
PYR + CoA + NAD ^ ACoA + CO2 + NADH +
Decarboxylation
H+
Citrate Synthesis
ACoA + OAA + H2O ^ CIT + CoA+ H+

1.044

0.116

20

Citrate Utilization

1.044

0.116

17
18

CIT + NAD+ ^ a-KG + NADH + CO2 + H+
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21

a-KG Utilization

a-KG + CoA + NAD+ ^ S-COA + CO2 +
NADH + H+

0.9396

0.1044

S-COA + ADP + Pi ^ SUC + ATP + CoA

0.9396

0.1044

SUC + (2/3)NAD+ ^ MAL + (2/3) NADH

1.044

0.116

23

Succinate
Formation
Malate Formation

24

Malate Utilization

MAL + NAD+ ^ OAA + NADH + H+

1.044

0.116

25

AcAc Formation

BHB + NAD+ ^ AcAc + NADH + H+

N/A

N/A

26

ACoA Formation
Glutamate
Formation
Glutamine
Utilization
Oxidative
Phosphorylation
ATP Utilization
Phosphocreatine
breakdown and
synthesis
ATP/ADP shuttle

AcAc + SCoA ^ ACoA + SUC

N/A

N/A

a-KG + NADH + H+ + NH4 ^ GLU + NAD+

N/A

N/A

0.0058

-0.0058

1.566

0.174

15.66

1.74

22

27

28
29

30

31
32

GLN + ADP + Pi ^ GLU + ATP

0.5 O2+ 3ADP + 3 Pi+ NADH + H+ ^ H2O +
3ATP + NAD+
ATP + H2O ^ ADP + Pi
PCr + ADP + H+ ^

Cr + ATP

Negligible Negligible
Negligible Negligible

Reactions in the GABA Shunt
33

GABA Formation

GLU ^ GABA + CO2

0.1044

0.0116

34

GABA Utilization

GABA + a-KG ^ SSA + GLU

0.1044

0.0116

35

SSA Utilization

SSA + NAD+ ^ SUC + NADH + H+

0.1044

0.0116

1.044

0.116

1.044

0.116

ASP MIT ^ ASP CYT

1.044

0.116

MAL cyt ^ MAL mit

1.044

0.116

GLU cyt ^ GLU mit

1.044

0.116

1.044

0.116

Malate-Aspartate Shuttle

Mitochondria
36

Aspartate
Formation

OAA + GLU ^ a-KG + ASP

Inter-compartment Transport

37

38
39
40

aKG shuttle
Aspartate
Transport
Malate shuttle
Glutamate
Transport

aKG mit ^ aKG cyt

Cytosol
41

OAA Formation
(CYTOSOL)

a-KGcYT + ASPcyt ^ OAA cyt + GLUcyt

120

42

OAA Utilization

OAA + NADH + H+ ^ MAL + NAD
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1.044

0.116

APPENDIX H
FURTHER TRANSFORMED FORMATION GIBBS FREE ENERGY (KJ/MOLE) OF
GLYCOLYSIS AND TCA CYCLE IN ASTROCYTES AND NEURONS

Species
Glc
G6P
F6P
F1,6BP
DHAP
GADP
1,3BPG
3PG
2PG
PEP
Pyr
Lac
AcCoA
OAA
Citrate
Iso-citrate
a-KG
SucCoA
Glutamate
Succinate
Fumarate
Malate

Astrocytes
-426.71
-453.48
-450.34
-476.15
-230.39
-222.73
-225.5
-231.5
-225.34
-74.145
-100.8
-122.55
10.03
-424.98
-599.88
-593.23
-444.51
-244.87
762.32
-321.66
-278.05
-429.39

Neurons
-379.16
-409.95
-406.85
-436.71
-210.72
-203.02
-203.96
-209.87
-203.77
-60.53
-101.30
-100.78
10.03
-424.98
-599.88
-593.23
-444.51
-244.87
762.32
-321.66
-278.05
-429.39
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APPENDIX I
EQUILIBRIUM CONSTANT (Keq ) OF METABOLIC REACTIONS OF

GLYCOLYSIS AND TCA CYCLE IN ASTROCYTES AND NEURONS

Metabolic reaction
GlcdG6P
G6PdF6P
F6PdF1,6BP
F1,6BPdDHAP
F1,6BPdGADP
DHAPdGADP
GADPd1,3PG
1,3PGd3PG
3PGd2PG
2PGdPEP
PEPdPyr
PyrdLac
PyrdAcCoA
AcCoA+OAAdCitrate
Citrate d Iso-citrate
Iso-citrated a -KG
a-KGdSucCoA
SucCoAd Succinate
SuccinatedFumarate
FumaratedMal
MaldOAA

Astrocytes
8.16E+05
1.50E+00
1.51E+04
2.67E+02
2.34E+01
2.97E-01
2.45E-01
8.41E-02
2.77E-02
1.23E-25
7.13E+04
4.06E+01
3.53E-19
3.29E-02
3.38E+30
5.41E-02
1.36E+41
3.45E-205
1.31E+13
3.07E-08
3.47E+25
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Neurons
8.16E+05
1.50E+00
1.51E+04
2.67E+02
2.34E+01
2.97E-01
6.60E-04
1.56E+00
2.43E-01
2.80E-25
1.14E+08
1.15E-01
3.53E-19
3.29E-02
3.38E+30
5.41E-02
1.36E+41
3.45E-205
1.31E+13
3.07E-08
3.47E+25

APPENDIX J
PARAMETER VALUES OF ASTROCYTES AND NEURONS
Astrocytes
Source

Product

VA(mM/min)

Neurons

VB(mM/min)

Glucose

G6P

1.67E+01

3.72E-06

VA(mM/min)

VB(mM/min)

2.95E+00

3.09E-06

KA(mM)

KB(mM)

Reference

0.1

0.47 Mulukutla, 2015
0.123 Mulukutla, 2015

G6P

F6P

9.26E+00

7.90E-01

1.63E+00

1.39E-01

0.96

F6P

F1,6BP

5.16E+01

1.24E-03

9.11E+00

1.03E-03

0.032

0.3 Mulukutla, 2015

F1,6BP

GAP

7.47E-01

1.96E-03

4.47E+00

7.21E-01

0.05

0.189 Mulukutla, 2015

DHAP

GAP

-1.88E+02

1.19E-01

8.30E+01

7.43E+02

0.43

0.162 Mulukutla, 2015

GAP

1,3PG

4.47E+01

8.60E-01

-4.80E+00

-8.72E-02

0.095

0.000671 Mulukutla, 2015

1,3PG
3PG

3PG

-1.06E-02

-1.48E+01

-1.35E-01

-2.62E+02

0.002

1.1 Mulukutla, 2015

2PG

1.00E-01

5.51E-01

-5.35E-01

-3.35E-01

0.168

0.0256 Mulukutla, 2015
0.11 Mulukutla, 2015

2PG

PEP

3.67E-26

7.14E-01

-1.99E-26

-1.71E-01

0.046

PEP

Pyruvate

-2.55E+00

-1.35E-04

-8.98E-01

-3.61E-06

0.225

Lactate

Pyruvate

1.68E+01

1.66E+00

5.59E-02

2.31E+00

0.87

Pyruvate

AcCoA

2.50E+00

5.66E+20

2.50E+00

5.66E+20

0.02

1.6 Mulukutla, 2015

AcCoA

Citrate

3.01E+01

2.54E-24

3.01E+01

2.54E-24

0.02

0.004 Mulukutla, 2015

OAA

Citrate

4.58E+02

1.10E+03

4.58E+02

1.10E+03

0.68

1.6 Mulukutla, 2015

Citrate

Isocitrate

6.75E+00

2.28E-42

6.75E+00

2.28E-42

0.0014

0.0238 Mulukutla, 2015

Isocitrate

alpha-KG

6.03E+00

4.03E-34

6.03E+00

4.03E-34

0.183

0.0069 Mulukutla, 2015

alpha-KG

SucCoA

2.20E-02

1.56E+203

2.20E-02

1.56E+203

0.15

0.0069 Mulukutla, 2015

SucCoA

SSA

3.00E-01

2.02E-10

3.00E-01

2.02E-10

0.055

1.275 Mulukutla, 2015

SSA

Fumarate

3.68E+02

9.41E+11

3.68E+02

9.41E+11

0.467

3.5 Mulukutla, 2015

Fumarate

Malate

1.80E+01

2.59E-26

1.80E+01

2.59E-26

0.0447

0.0055 Mulukutla, 2015

Malate

OAA

4.85E+00

3.47E+02

4.85E+00

3.47E+02

0.11

1.6 Mulukutla, 2015

4 Mulukutla, 2015
0.2 Lowry, 1964

Ka and Kb take from literatures, and Va and VB are calculated by Keq and species steady
state concentrations.
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APPENDIX K
REACTION GIBBS FREE ENERGY Ar^y"0(KJ/MOLE) FOR GLYCOLYSIS AND

TCA CYCLE IN ASTROCYTES AND NEURONS
Source
Glucose
G6P
F6P
F1,6BP
DHAP
GAP
1,3PG
3PG
2PG
PEP
Lactate
Pyruvate
AcCoA
OAA
Citrate
Isocitrate
alpha-KG
SucCoA
SSA
Fumarate
Malate

Product
G6P
F6P
F1,6BP
GAP
GAP
1,3PG
3PG
2PG
PEP
Pyruvate
Pyruvate
AcCoA
Citrate
Citrate
Isocitrate
alpha-KG
SucCoA
SSA
Fumarate
Malate
OAA

Astrocytes
-26.77
3.14
-25.81
253.42
7.66
-2.77
-6
6.16
151.195
-26.655
21.75
110.83
-609.91
-174.9
6.65
148.72
199.64
-76.79
43.61
-151.34
4.41
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Neurons
-30.79
3.1
-29.86
233.69
7.7
-0.94
-5.91
6.1
143.24
-40.77
-0.52
111.33
-609.91
-174.9
6.65
148.72
199.64
-76.79
43.61
-151.34
4.41

